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1. AN OVERVIEW OF THE RESEARCH OUTPUT 
 Nosocomial infections (NI) have been serious problems for hospitalized patients 
where almost half of all the infections are device related. Various polymeric materials 
including polyesters and polyamides such as polyethylene terephthalate – PET and Nylon 6 
are widely utilized for clinical devices. These polymers are commonly used in biomedical 
applications ranging from catheters to stents, vascular grafts, heart valves, wound dressings, 
sutures and scaffolds. Polymer surface modification is very essential factor to improve and 
impart desired properties for biomedical applications, making the polymers biocompatible, 
non-cytotoxic and antibacterial that can preferably resist biofilm formation caused by 
pathogenic bacteria.  
 At first, novel approach to anti-corrosive wet chemical surface modification of PET by 
insertion of alkyl and hydroxyl groups was achieved by using different Grignard reagents and 
confirmed by several different characterization techniques including water contact angle 
(WCA) measurement, free surface energy (FSE) measurement, fluorescence intensity test 
after fluorescence labelling with dansyl chloride, scanning electron microscopy (SEM) and 
atomic force microscopy (AFM). High antibacterial efficiency against four different types of 
biofilm active, pathogenic bacterial strains namely: Staphylococcus aureus, Escherichia coli, 
methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa was 
established on the modified PET surface. Biocompatibility much higher than 70 % of the 
modified samples has been proved.  
 Our second studies were focused on an efficient reduction of amide functional groups 
to secondary amine on Nylon 6 film surface with borane-tetrahydrofuran (BH3-THF) complex, 
followed by N-alkylation with benzyl chloride (C6H5CH2Cl) as well as grafting on reduced 
Nylon 6 surface by using poly(ethylene glycol) methyl ether tosylate (H3C-PEG-OTs). The 
different N-alkylation reactions allowed us to tune the surface properties of Nylon 6. Thus 
obtained modified Nylon 6 polyamide can be useful for many applications including 
antifouling biomaterials as the polyamide after functionalization was found to be 
biocompatible and resistant to pathogenic bacterial adhesion due to the presence of 
hydrophilic poly(ethylene glycol) methyl ether (H3C-PEG) chains after grafting. Not only that, 
the grafting intensity was regulated also by the duration of preceding lithiation reaction 
before grafting. The grafted Nylon 6 samples were further modified by physical assemblage 
of copper nanoparticles (Cu NPs) on the surface. Another modification route was also 
examined for PEG immobilization on reduced Nylon 6 surface via N,N′-disuccinimidyl 
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Carbonate (DSC) conjugation. The surface modifications were confirmed by different 
techniques. Water contact angle (WCA), free surface energy (FSE) analyses indicated the 
significant change in the surface morphology that were established by scanning electron 
microscopy (SEM), atomic force microscopy (AFM), X-ray photoelectron spectroscopy 
(XPS), Fourier-transform infrared spectroscopy (FT-IR) and Raman spectroscopy. The 
pathogenic bacterial strains: Gram positive Staphylococcus aureus and Gram negative 
Pseudomonas aeruginosa were used to depict the antibacterial efficacy. The resistance to 
bacterial adhesion has been established for the grafted and Cu NP deposited modified Nylon 
6 samples. Most of the modified samples were established to be cytocompatible.  
 Simultaneously, our focus was to synthesize the copper nanoparticles (Cu NPs) for 
the deposition on grafted Nylon 6 surface to examine the possibility of Cu NP physisorption 
on surface as well as to evaluate the antibacterial efficacy of prepared Cu NP deposited 
Nylon 6 samples. The synthesized Cu NPs were characterized by various methods including 
dynamic light scattering (DLS), scanning electron microscopy (SEM), UV-VIS spectroscopy 
and Fourier-transform infrared spectroscopy (FT-IR). 
 The last but not least study was concentrated on synthesis of mesoporous silica 
nanoparticles (MSNs) that are widely studied for drug delivery. The resulting mesoporous 
surfaces are now conveniently prepared making use of recently published collection of 
carefully verified synthetic procedures. The MSNs thus obtained were characterized by 
Brunauer-Emmett-Teller (BET) analysis and scanning electron microscopy (SEM). The 
selected MSNs with various pore diameters and morphologies were examined to evaluate 
the capability of L-DOPA drug loading and release that is a well-known drug for Parkinson’s 
disease. The L-DOPA drug loading and release profiles were measured by UV-VIS 
spectroscopy and SBA-15 was proved to be the most effective amongst all the different 
types of tested mesoporous silica materials. 
Keywords: pathogenic bacteria, polyethylene terephthalate, Nylon 6, mesoporous silica 






1. PŘEHLED VÝSLEDKŮ 
 Nosokomiální infekce (NI) představují významný problém pro hospitalizované 
pacienty kde téměř polovina infekcí je zprostředkována nerůznějšími lékařskými nástroji. 
Tyto nástroje obsahují části nebo jsou celé z polymerních materiálů typu polyamidů (např. 
Nylon 6) a polyesterů (např. PET). Tyto polymery se běžně používají v řadě zavedených 
biomedicinských aplikací, jako jsou katetry, stenty, srdeční chlopně, krycí materiály pro 
popáleniny a řadu dalších pomocných materiálů. Modifikace povrchu těchto a dalších 
polymerů je jednou z možností jak upravovat vlastnosti a s nimi spojenou aplikovatelnost 
těchto biomedicinských materiálů. Vhodnou funkcionalizací povrchu lze dospět 
k matertiálům biokompatibilním, antibakteriálním, a/nebo rezistentním k tvorbě a ulpívání 
biofilmu.  
 V první části byl rozpracován postup pro modifikaci povrchu polyesterů (konkretně 
PET) využívající reakci esterových funkcí s Grignardovými a organolitnými organokovovými 
činidly. Reakcí se do povrchové vrstvy vnáší hydroxylová skupina, ale zároveň i dva 
organické zbytky, odpovídající použitému organokovovém činidlu. Tím lze povrchovou vrstvu 
modifikovat v širokých mezích. Reakci lze monitorovat řadou technik, zde bylo využito 
měření kontaktního úhlu, volné povrchové energie, měření fluorescenční intenzity (po 
vhodném fluorescenčně aktivním označení účinkem dansyl chloridu). Vedle toho byly 
interpretována data SEM, AFM, i IČ analýz. Biologická aktivita modifikovaných povrchů byla 
testována na kmenech: Staphylococcus aureus, Escherichia coli, methicillin-resistentní 
Staphylococcus aureus (MRSA) a Pseudomonas aeruginosa. Biokompatibilita vyšší než 70 
% byla zjištěna u některých materiálů s modifikovanou povrchovou vrstvou.  
 Druhá část popisuje studii, jejíž podstatou je aplikace účinné redukce amidické 
funkce polyamidů (zde Nylon 6) účinkem diboranu a jeho komplexů. Tato reakce byla ihned 
následována funkcionalizací (alkylací) vznikajícího aminu. K tomu bylo využito benzyl 
chloridu (C6H5CH2Cl) a poly(ethylen glycol) methyl ether tosylátu (H3C-PEG-OTs). Volbou 
alkylačních činidel bylo možné měnit povrchové vlastnosti výchozích polyamidů v širokých 
mezích. Takto získaný modifikovaný Nylon 6 vykazoval zajímavé vlastnosti se silně 
potlačenou tvorbou biofilomu. Výsledné vlastnosti polymeru byly závislé nejen na použitém 
činidle, ale také na využitých reakčních podmínkách. Pro další funkcionalizaci byly využity i 
nanočástice Cu spontánně tvořící povlak na Nylonu 6. Byl vyzkoušen i jiný postup 
funkcionalizace redukovaného polyamidu účinkem N,N′-disukcinimidyl karbonátu (DSC). 
Vlastnosti takto získaných modifikovaných povrchů byly testovány s využitím analogických 
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metodik a postupů, které se osvědčily u polyesterů. Většina vzorků s modifikovanými 
povrchy byla shledána jako cytokompatibilní.  
 Ve třetí části jsou popsány naše výsledky při syntéze Cu NPs, které byly využity pro 
funkcionalizace polyamidů. Vzniklé nanočastice byly charakterizovány s využitím běžných 
metod a postupů jako jsou: dynamický rozptyl světla (DLS), elektronová mikroskopie (SEM), 
UV-VIS a FT-IR spektroskopie. 
 V poslední, čtvrté části této práce jsou popsány výsledky získané aplikací 
testovaných syntéz mesoporézních křemičitých nanočástic (MSNs). Ty byly testovány 
především jako nosiče dopaminu, což je neurotransmiter, využívaný při zpomalování projevů 
jinak neléčitelné Parkinsonovy nemoci. Tvorba a uvolňování L-DOPA byla měřena pro různé 
morfologie částic i tvar pórů MSNs. Využili jsme pro to opět spektrální metody. Výsledkem 
tohoto výzkumu je zjištění, že komerčně dostupný MSN typu SBA-15 vykázal v tomto ohledu 
nejvyšší účinnost.  
Klíčová slova: patogenní bakterie, polyethylentereftalát, Nylon 6, mesoporézní silika 













AFM    atomic force microscopy 
BET    Brunauer–Emmett–Teller 
BH3    borane 
BJH    Barret-Joyner-Halenda 
CH3-PEG-OTs  poly(ethylene glycol) methyl ether tosylate 
CMC    critical micelle concentration 
CTAB    hexadecyltrimethylammonium bromide 
Cu NPs   copper nanoparticles 
DEE    diethyl ether 
DFT    density functional theory 
DLS    dynamic light scattering   
DLVO   Derjaguin-Landau-Verwey-Overbeek 
DMEM   Dulbecco’s Modified Eagle’s Medium 
DMSO   dimethyl sulfoxide 
DNSC    dansyl chloride 
DSC    N,N′-disuccinimidyl carbonate 
EPS    extracellular polymeric substance 
FT-IR    Fourier transform infrared spectroscopy 
FSE    free surface energy 
HAI    hospital acquired infections 
KIT    Korea Advanced Institute of Science and Technology type material 
LCP    liquid crystal polymer  
L-DOPA   3-(3,4-dihydroxyphenyl)-L-alanine 
MCF    mesostructured cellular foam 
MCM    mobil crystalline material 
MCM-41(FS)   MCM-41 prepared be fumed silica 
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MCM-4 (HO)   highly ordered MCM-41 
MCM-41(S)   MCM-41 with spherical morphology 
MRSA   methicillin-resistant Staphylococcus aureus 
MSNs    mesoporous silica nanoparticles 
MSU    Michigan State University material 
MTT    3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
n-BuLi   n-butyllithium  
NI    nosocomial infection 
NC    negative control 
NPs    nanoparticles 
P123    poly(ethylene glycol)-block-poly(propylene glycol)-block-  
   poly(ethylene glycol) 
PA    polyamide 
PAAm   polyacrylamide  
PAANa   sodium salt of poly(acrylic acid)  
PC    polycarbonates (in polymer) 
PC    positive control (in cytotoxicity test) 
PDLA    poly(D-lactic acid)  
PDMS    polydimethylsiloxane 
PE    polyethylene 
PEG    polyethylene glycol 
PEG-CH3   poly(ethylene glycol) methyl ether  
PET    polyethylene terephthalate 
PGA    polyglycolic acid  
pHEMA   polyhydroxyethyl methacrylate  
PHTS    plugged hexagonal templated silica 
PLLA    poly(L-lactic acid)  
PMMA   polymethylmethacrylate  
7 
 
PP    polypropylene    
PTFE    polytetrafluoroethylene  
PU    polyurethane  
PVC    polyvinyl chloride  
S1    pure Nylon 6 
S2    reduced Nylon 6: Nylon 6-NH 
S3    grafted Nylon 6: Nylon 6-N-PEG-CH3 (2 h lithiation, 0.6 ml t-BuLi) 
S4    grafted Nylon 6: Nylon 6-N-PEG-CH3 (24 h lithiation, 0.6 ml t-BuLi) 
S5    grafted Nylon 6: Nylon 6-N-PEG-CH3 (2 h lithiation, 1 ml t-BuLi) 
S6    grafted Nylon 6: Nylon 6-N-PEG-CH3 (24 h lithiation, 1 ml t-BuLi) 
S7    grafted Nylon 6: Nylon 6-N-PEG-CH3 (2 h lithiation, 2 ml t-BuLi) 
S8    grafted Nylon 6: Nylon 6-N-PEG-CH3 (24 h lithiation, 2 ml t-BuLi) 
S9    copper nanoparticle deposited Nylon 6: Nylon 6-N-PEG-CH3-Cu 
SBA    Santa Barbara amorphous type material 
SDS    sodium dodecyl sulphate 
SEM    scanning electron microscopy 
t-BuLi    tert-butyllithium 
t-BuOK   potassium tert-butoxide 
TCP    tissue culture plastic  
TEAOH   tetraethylammonium hydroxide 
TEM    transmission electron microscopy 
TEOS    tetraethyl orthosilicate 
THF    tetrahydrofuran 
UV-VIS   ultra violet and visible spectroscopy 
WCA    water contact angle 





2.1. Pathogenic Bacteria: Health Care Associated Infections 
 There are millions of prokaryotic microorganisms, known as bacteria, exist on our 
planet forming a biomass that exceeds all the plants and animals on Earth [1]. Bacteria are 
small and structurally simple, compared to the vast majority of eukaryotic cells. Most can be 
classified broadly by their shape as rods (bacilli), spheres (cocci), or spirals (spirochetes) 
and by their cell-surface i.e. cell wall structure (Gram positive and Gram negative). Although 
bacteria lack the elaborate morphological variety of eukaryotic cells, they display a surprising 
array of surface appendages that enable them to swim or to adhere to desirable surfaces. 
Their genomes are correspondingly simple [2]. Most bacteria are harmless or often 
beneficial, but some of them can cause infectious diseases by invading our body and are 
called as pathogenic bacteria, with the number of species estimated as fewer than 100 [3]. 
By contrast, several thousand species exist in the plant and animal body system including 
human.  
 Each species of pathogen has a characteristic spectrum of interactions with its 
human hosts. The skin, the mucosal surfaces (oral cavity, nasopharynx, urogenital tract) and 
deeper tissues (lymphoid tissue, gastric and intestinal epithelia, alveolar lining and 
endothelial tissue) are the primary sites of host–microbe interaction. Pathogenic bacteria 
infect human under conditions that favour their growth and survival. Pneumonia and 
diarrhoea together are the third cause of death among children under 5 years of age 
worldwide, accounting for 2 million deaths per year [4]. The cell walls of both Gram positive 
and Gram negative bacteria contain toxic components that are potent virulence factors and 
have central roles in the pathogenesis of bacterial septic shock, a frequently lethal condition 
that involves collapse of the circulatory system and may result in multiple organ system 
failure. Bacteria frequently implicated in septic shock include Gram negative microbes such 
as Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), and meningococci, 
and Gram positive bacteria such as Staphylococcus aureus (S. aureus), Staphylococcus 
epidermidis, and streptococci. [5]. Interestingly, the mentioned group of Gram positive 
bacteria have emerged as the most prevalent cause of hospital acquired infections (HAI), 
and as such, play a significant part in nosocomial sepsis.  
 According to the World Health Organization a Hospital-Acquired Infection (HAI), also 
known as nosocomial infection (NI) is, “an infection acquired in hospital by a patient who was 
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admitted for a reason other than that infection. This includes infections acquired in the 
hospitals but appearing after discharge and also occupational infections among staff of the 
facility”. In other words, nosocomial infections (NIs) are those infections acquired in hospital 
or healthcare service unit that first appear 48 hours or more after hospital admission or 
within 30 days after discharge following in-patient care [6]. NIs pose a constant threat to 
hospitalized individuals. In some studies, HAI rates have ranged from 1% in countries like 
Europe and North Americas to more than 40% in certain parts of Asia, Latin America and 
sub-Saharan Africa. However, there remains a problem with measuring the exact incidence 
of HAIs due to varying definitions for specific infections [7]. NIs cause prolonged hospital 
stay, increased antimicrobial resistance, long-term functional disability and emotional stress 
of the patient and in some cases, may lead to conditions that reduce the quality of life. The 
costs of nosocomial infections in terms of both money and human suffering are enormous 
[6,8]. There are various types of NIs such as central line-associated bloodstream infections 
due to prolonged use of catheters, catheter associated urinary tract infections, surgical site 
infections mainly caused by Staphylococcus aureus and ventilator associated pneumonia 
[8,9].  
2.2. Biofilm and Infection on Medical Devices 
 In terms of biomass on the Earth, bacteria are the most successful forms of life in 
survival at different environments due to their phenotypic plasticity [10]. Biofilms are matrix-
enclosed bacterial populations adherent to each other and/or to surfaces or interfaces and 
affect almost all surfaces including metals, glass, textile, polymers; causing damages to 
various industries, most importantly biomedical fields by contaminating medical devices [11]. 
In spite of the considerable success achieved with these devices, their abiotic surfaces are 
susceptible to bacterial colonization, particularly by pathogenic bacteria which is forming an 
important and challenging public health problem. More than 60 % of nosocomial infections 
(NIs) worldwide are accredited to pathogenic bacteria forming biofilms on medical devices as 
biofilm bacteria show a 10 – 1000 times higher resistance towards antibiotics than planktonic 
bacteria [12]. This has become a major healthcare concern as antibiotic-resistant bacterial 
strains like methicillin-resistant Staphylococcus aureus (MRSA) are increasing [13]. When a 
medical device is contaminated with microorganisms, several factors determine whether a 
biofilm develops. First, the microorganisms must adhere to the exposed surfaces of the 
device long enough to become irreversibly attached [14]. The bacterial attachment on device 
also depends on physicochemical characteristics, number as well as types of cells in the 
liquid and protein adsorption on the surface [11]. Biofilms usually occur on or within 
indwelling medical devices such as contact lenses, central venous catheters, mechanical 
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heart valves, peritoneal dialysis catheters, prosthetic joints, pacemakers, urinary catheters 
and voice prostheses. Biofilms may be composed of only a single or of different types of 
microbial species depending on the nature of the device [15].  
 Biofilm development can be divided into three distinct stages: firstly, the attachment 
of cells to a surface, secondly, the growth of the cells into a sessile biofilm colony, and lastly, 
detachment of cells from the colony into the surrounding medium. In the first stage, the 
initial, reversible interaction between a bacterial cell and a surface is mediated that can be 
explained by  bacterial adhesion model using Derjaguin-Landau-Verwey-Overbeek (DLVO) 
theory or by thermodynamic approaches [16]. The attachment is reinforced by host- and 
tissue-specific adhesins that are located on the bacterial cell surface or on cellular 
appendages such as pili and fimbriae. This results in the irreversible attachment of the 
bacterial cell to the surface. The second stage of biofilm development involves the 
multiplication of bacteria on the surface and synthesis of an extracellular polymeric 
substance (EPS) [17]. The produced matrix holds the bacterial cells together in a mass and 
firmly attaches the bacterial mass to the underlying surface. It is worth to be mentioned that 
the matrix also contributes to biofilm- mediated antimicrobial resistance, either by acting as a 
diffusion barrier, or by binding directly to antimicrobial agents and preventing their access to 
the biofilm cells. In the third stage, continued growth of bacterial cells on a surface leads to 
the development of mature biofilm colonies containing millions of tightly packed cells 
gathered into pillar and mushroom-shaped masses that project outward into the surrounding 
medium for hundreds of microns. The matured biofilm colonies are complex due to the 
presence of numerous micro- environments with various metabolic activities, fluid-filled 
channels for the exchange of nutrients as well as waste products and heterogeneity in 
reproductive activity among cells. At the final stage of mature biofilm, the cells are detached 
from the biofilm colony and dispersed into the environment. This is an essential stage of the 
biofilm life cycle that contributes to biological dispersal, bacterial survival, and disease 
transmission [18,19]. The mechanism of biofilm formation is depicted by the Figure 1.  
 Theoretically, biofilm formation on medical devices can be prohibited by altering the 
device's surface using different strategies like mechanical, physical and chemical methods to 
prevent bacterial attachment, or by including antibacterial therapeutics in the device to 
prevent early stages of biofilm formation [20]. Ideally, preventing biofilm formation would be 
a more logical option than treating it. However, there is presently no known technique that is 
able to successfully prevent or control the formation of unwanted biofilms without causing 




Figure 1: Formation of biofilm by adhesion of planktonic bacteria on the surface. 
2.3. Importance of Biomaterial’s Surface Modification for Biomedical 
Application: Key Strategies 
 The biomedical implants and devices undoubtedly enhance the quality of our lives by 
extending the functionality of essential body systems beyond their supposed lifespans. 
Across the medical industry, various implants and devices have been studied and developed 
for multiple applications in the human body. In the biomedical field, the high demand for 
medical implants and devices is expected to increase in the future. According to the U.S. 
Food and Drug Administration, a medical device is “an instrument, apparatus, implement, 
machine, contrivance, implant, in vitro reagent, or other similar or related article which is 
used in the diagnosis, cure, mitigation, treatment or prevention of a disease, or intended to 
affect the structure of any function of the body which does not achieve its primary intended 
purpose through chemical action within or on the body” [22]. Implants are objects that do not 
require any form of power for the device to carry out its expected functions. Devices are 
objects that require a form of power, which may be chemical or electrical [22]. Any 
substance that is used to be in contact with living tissue and biological fluids without 
adversely affecting the biological constituents of the entire living organism is named as 
biomaterial [23].  
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 Biomaterials can be composed of metals, ceramics and polymers or their 
composites. Unlike 20th century, in 21st century the biomaterial are not expected to be inert 
as they do not elicit immunological primary or secondary foreign body reaction.  Biofilms can 
easily develop on inert biomaterial’s surface or on dead tissue. Sessile bacteria release 
antigens and stimulate the antibody production. But the antibodies fail to kill biofilm 
embedded bacteria. Depending on the type and composition of the medical device, some 
pathogens are more prevalent. In most of the cases, the occurrence of acute infection 
obligates the removal of the device. [24]. On the contrary, the use of bioactive materials 
helps to integrate properly with the surrounding tissue [25]. Recently, biomaterials’ surface 
modification has gained enormous importance in the research domains to improve the 
device multi-functionality, topography, hydrophilicity/ hydrophobicity, free surface energy and 
biocompatibility/ cytocompatibility [26]. Usually, more than one approach is needed to satisfy 
the requirements of biomaterials [23].  
 It is extremely important to study and understand the fundamental aspects of the 
biological responses to biomaterials as a series of reactions take place between the host 
and biomaterial after implanting or placing them in contact of physiological fluids. Firstly, the 
water and protein adsorption take place, followed by provincial matrix formation, cell 
attachment and new tissue growth on the biomaterial. This may lead to inflammation, foreign 
body reaction and scar development [27].  
 To combat these problems, various strategies have been developed by researchers. 
There are predominantly four different techniques that can be employed for the change in 
functionality of material surface. These methods are elaborated below [23]:  
1) Physical methods: physical adsorption, surface micro/ nano-patterning, Langmuir–
Blodgett film deposition etc. 
2) Chemical methods: ozone treatment, silanization, fluorination, wet treatments such 
as aminolysis and alkaline or acidic hydrolysis, incorporation of functional groups by 
grafting polymerization or hydrogel coating, flame treatment etc. 
3) Biological methods: Protein–Enzyme Immobilization 
4) Radiation Methods: Plasma Radiation, Microwave and Corona Discharge, 
Photoactivation by UV. Laser, Ion Beam, Gamma Irradiation etc. 
 The anti-infective strategies can be developed similarly by the above mentioned 
approaches either to prevent bacterial adsorption and adhesion, or to kill bacteria [28].  
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2.4. Polymers Used in Biomedical Applications 
 The natural fibres like horn, hair, or polymers like cellulose have been utilized by 
human since the beginning of human civilization, and they have found application in health 
care, e.g. as suture material also for long time. However, since the advent of the man-made 
polymers, such materials have attracted great attention and interest in various applications in 
the medical field for various reasons.  A wide range of physical and chemical properties can 
be achieved based on the monomer units, polymerization reaction and formation of co-
polymers consisting of different components at adjustable concentrations imparting desirable 
mechanical and structural properties  [29].  The most common functional groups present on 
biomedical polymers are carboxyl (–COOH), hydroxyl (–OH), amino (–NH2), and methyl (–
CH3) groups [30]. In the modern world, there are many polymers that have been developed 
and are continuously being developed by the scientists for biomedical industry. The 
polymeric biomaterials can be classified in various ways based on different attributes 
(adhesiveness, degradability, hydrophilicity etc.). Some of the commonly used biomedical 
polymers are listed below [22,29]. 
1) Polyolefins: Polyethylene (PE) and polypropylene (PP) are inert and hydrophobic 
materials which do not degrade in vivo. These polymers are mainly applied for 
epidural catheters, implantable cardioverter/defibrillator, pacemaker, Foley catheters, 
nasal implants for nose reconstruction, central venous access device and 
orthopaedic implants. 
2) Polytetrafluoroethylene (PTFE): It is commercially known as Teflon® and has an 
ethylene backbone with four covalently bound fluorine molecules. Left Ventricular 
Assist Device, epidural catheters, implantable cardioverter/defibrillator, pacemaker, 
neuro-stimulator in sacral nerve stimulation, synthetic blood vessels, hip implant and 
many ophthalmic devices are made up of PTFE. 
3) Silicone: Silicones consist of an –Si–O– backbone with different chain lengths and 
crosslinks, which determine mechanical properties. The side chains may be modified, 
but in the most common polydimethylsiloxane (PDMS) they are methyl groups. 
Mechanical heart valves, artificial blood vessels, catheters, cochlear implants, stapes 
implants, penile implants, artificial urinary sphincter implant, breast implants and 
many other implants’ materials are considered to be PDMS. 
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4) Methacrylates: Methyl methacrylates polymerize to very rigid polymers namely 
polymethylmethacrylate (PMMA) by radical polymerization and therefore find 
application in dentistry, ophthalmic and orthopaedics. The hydrophilic side chains in 
the hydroxyethyl methacrylate monomer lead to the polymerization to a hydrogel 
polyhydroxyethyl methacrylate (pHEMA). This has good protein repellent anti-fouling 
properties. 
5) Polyesters: Bio-stable and biodegradable polyesters are used in biomedicine. Bio-
stable polyesters contain aromatic groups, for examples polycarbonates (PC), 
polyethylene terephthalate (PET). Polyesters of small aliphatic glycolic acid or lactic 
acid present the most common degradable polymers such as polyglycolic acid 
(PGA), poly(L-lactic acid) (PLLA) and poly(D-lactic acid) (PDLA). The bio-stable 
polyesters are used for synthetic blood vessels, cheek, jaw and chin implants, 
catheter etc. The biodegradable polymers are available in different shapes from solid 
body for orthopaedic applications, via meshes to drug eluting coatings on vascular 
stents. 
6) Polyamides (PA): All proteins consist of units linked by amide (–CONH2–) bonds. 
The highly repetitive proteins like collagen or silk fibroin can be classified as 
polyamides. The most important synthetic polyamide with clinical application is Nylon 
due to its high tensile strength, and is used for suture materials. Polyamide block-
copolymers combine the flexibility of polyurethanes with the strength of Nylon and 
therefore, became the material of choice for the balloon of catheters for angioplasty. 
7) Polyethers, polyurethanes (PU), polyvinyl chloride (PVC), polyhydroxyalkanoates, 
liquid crystal polymer (LCP) are also considered to be effective biomaterials and 
widely used in the clinical fields. There are many more polymers that are under 
extensive biomedical research. 
 Structures of some previously mentioned common polymers widely used in 




Figure 2: Structures of common biomedical polymers. 
 The major approaches to develop the antifouling polymer surface involve two major 
strategies: a) resisting protein adsorption as well as bacterial adhesion and b) incorporating 
bactericidal coating [31].  
a) Antifouling approach by protein resistance 
Protein adsorption and formation of protein layer on the surface provide a 
conditioning layer for colonization of microbes that subsequently leads to the biofilm 
formation as well as reduces the device’s efficacy [32,33]. There are various key procedures 
for surface modifications and preparation of coatings that resist protein adsorption and thus 
prevent bacterial adhesion [28,34–40]. Immobilizing cytocompatible hydrophilic polymer 
polyethylene glycol (PEG) on the surface is one of the most commonly used trends to 
contribute both protein and bacterial resistance [41–46]. The polyethylene glycol (PEG) and 
its derivatives, in different lengths or with different functional groups [47] have been applied 
to maximize the antifouling effect. Unfortunately, the exact mechanisms of PEGs for 
repelling bacteria are still unclear. But various studies revealed that surface modification with 
PEG contributes to protein as well as bacteria repellence to the surfaces due to high polymer 
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flexibility, large excluded volume, hydrophilicity, and associated steric hindrance effects [48]. 
A significant decrease in bacterial adhesion and biofilm formation was confirmed in case of 
the PEG modified surfaces [31]. Some studies suggest interconnection between the 
antifouling property and molecular weight of the PEG bonded to the surface. Dong et al. 
designed antifouling surfaces by grafting polyethylene glycol of various molecular weights 
(PEG MW 200, 400, 600, 2000, and 4600). The maximum decrease in bacterial adhesion has 
been observed with PEG having a MW 2000 [49].  
The other antifouling approaches are largely based on self-assembled monolayers 
(SAMs) containing different functional groups [50], zwitterionic surface [51,52], peptide-
based surface [53], photo-activated self-cleaning films [54,55], smart materials [56]. 
b) Bactericidal coating 
 The bactericidal coatings include silver releasing coatings [57], copper/ copper alloy 
embedded surface [58,59], antibiotic releasing coatings [60], photo-activated antibacterial 
coatings [55], non-release based polycation coating [61], release-based antibacterial coating 
[62]. 
In our research work, we have used the following two biomedical polymers: PET and 
Nylon 6. These two polymers and their surface modifications aiming to improve the 
biomedical efficacy are discussed in detail. 
2.4.1. Polyethylene terephthalate (PET) 
 Polyethylene terephthalate – PET is one of the most common polymers widely used 
in medicine. Biocompatible, chemically inert PET (Dacron®) biomaterials, in combination 
with different coatings [63,64], are used in surgical meshes, vascular grafts, heart valves, 
scaffolds, sutures, urinary and bloodstream catheters. The techniques applied for better 
performance of biomedical PET are discussed below. 
 PET vascular grafts are coated with either collagen or albumin protein [65] or heparin 
[66]. PET with polyacrylamide (PAAm; hydrophilic and neutral) and PET with sodium salt of 
poly(acrylic acid) (PAANa; hydrophilic and anionic) elicit an anti-inflammatory response in 
macrophages [67]. Very little information is available regarding the PET urinary catheter 
coatings. Non-thrombogenic PET biomaterials can be fabricated with PEG (polyethylene 
glycol) or oligo(ethylene glycol) groups, sometimes grafted with peptides [31,68,69]. Studies 
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revealed that silver-coated prosthetic heart valve sewing cuffs and sutures have anti-
infective potential in vitro [70]. Various biomedical coatings (hydroxyapatite, bioactive glass, 
hydroxypropylcellulose, hyaluronic acid, polystyrene sodium sulfonate composite coating) 
are applied on PET artificial ligaments [71]. But in spite of rigorous research works in various 
parts of the world, the desired permanent solution is yet to be found.  
 PET, generally known as a thermoplastic polymer resin, belongs to the polyester 
family and is used in both domestic and industrial domain. Two monomers, modified 
ethylene glycol and purified terephthalic acid, are combined to form PET, which is usually 
prepared by ester exchange reaction of dimethyl terephthalate with ethylene glycol [72]. For 
the improvement of general and specific applications of chemically inert PET, it is necessary 
to find new approaches to the surface modification chemistry. Different useful techniques to 
introduce various functional groups on the surface of PET, without changing its bulk 
properties, have been explored by scientists in the PET research field including plasma 
treatment [73], radiation [74], hydrolysis [75,76], aminolysis [77,78], graft co-polymerization 
[79,80], enzymatic modification [81], PEG grafting [82] etc. PET surface modification imparts 
various desirable properties like dyeability, surface roughness, altered hydrophobicity, 
biocompatibility and many more. These new and modified surface properties are 
implemented in the fields of modern textile [83], filtration [84], biomaterials [85,86], and most 
recently in nanotechnology [87]. 
 Straight chemical modification for PET surfaces by wet chemistry is usually very 
difficult due to the absence of chemically reactive groups. The effective means for PET 
surface modifications are hydrolysis [88] and aminolysis [77]. Hydrolysis produces mixture of 
hydroxyl and carboxylic functional groups, while aminolysis incorporates amine groups to the 
PET surfaces. The surface chain cleavage, in both types of reactions, can lead to significant 
sample degradation. Thus the reaction conditions are optimized with aim to maximize 
conversion and minimize corrosion. Based upon the mentioned reactions, the series of 
surface modification techniques have been developed to improve the modern PET 
applications. Another method, wherein the monomers can be attached onto the polymer 
chains via covalent bond, is grafting. It can be initiated by the chemical reaction, photo-
irradiation and plasma treatment [88–92]. 
2.4.2. Nylon 6 
Nylon 6, also known as polycaprolactam, is a commercialized polymer that is widely 
used in biomedical field because of its strength, flexibility, toughness and biocompatibility 
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[93]. During Second World War, newly developed man-made synthetic polymers like 
polyamides rapidly entered medical application field [29]. The biomedical applications of 
polyamides include suture material, coated textile for skin infection, wound dressing, 
catheters, bone tissue scaffolds and dialysis membranes [94–99]. But without modification of 
polymer surface, it may cause various problems like thrombogenesis [100]. Therefore, 
surface chemistry plays very important role for further modification of polymeric surface by 
introducing specific functional groups, which improve its performance.  
 Nylon 6 membranes comprise only a low concentration of terminal amino 
groups, thus amides conversion into amines should allow a more homogenous distribution of 
activated Nylon 6 surface [101]. Nylon 6 surfaces are modified by either physical or chemical 
methods. The first category includes particularly the treatment with UV radiation or plasma 
[100], [102–104], but lack of the well-designed surface formation generally leads to the 
limitations in the using of physical methods. Jia et al. [93] surveyed a variety of chemical 
reactions applicable to the amide repeating units and described that a more efficient 
modification approach is application of chemical methods by reaction at the amide groups 
through hydrolysis, O-alkylation and N-alkylation. Inman et al. [105] studied enzymes 
immobilization on Nylon 6 structures by their partial hydrolysis with hydrochloric acid, 
followed by covalent attachment of different enzymes through glutaraldehyde. O-alkylation 
related to Nylon 6 tubes was achieved by using dimethyl sulfate, diethyl sulfate or 
triethyloxonium tetrafluoroborate as alkylating agents to covalently attach enzymes, either 
directly or via cross-linking agents [106,107]. Cairns et al. [108] investigated polyamides N-
alkylations by using formaldehyde in presence or absence of alcohols and mercaptans. 
Beeskow et al. [101] activated terminal Nylon 66 amino groups by N-alkylation for dextran 
immobilization. Another example  regarding N-alkylation includes Nylon 66 yarns cross-
linking, which has been achieved by reaction with diisocyanates and diacid chlorides [109]. 
Recently, chitosan derivatives, peptides, collagen, PEG and other biocompatible compounds 
have been immobilized on polyamide surfaces either by chemical treatment or physical 
methods, mostly plasma treatments  [82,110,111]. Herrera-Alonso et al. [112] reported that 
Nylon 6 reduction carried out with BH3-THF was the most efficient method for introducing 
secondary amine groups to the Nylon 6 surface. Surface amides conversion into amines 
generally provides more versatility in terms of the opportunity to introduce covalent bonding 
with other different functional groups for long-term use.  
In the field of biomedicine, Nylon materials are physically or chemically modified 
according to the requirements. One of the common physical modification techniques is 
employing laser at various parameters to alter surface topography [113,114]. Hydroxyapatite 
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or calcium phosphate coatings on Nylon has been studied for bone tissue engineering 
[115,116]. Silver coated Nylon for wound dressing [97], chemical treated [117] and carbon 
nanoparticle immobilized Nylon [118] have been also explored.    
2.5. Nanoparticles (NPs) 
 The NPs are tiny colloidal particles having size ranging from 1 to 100 nm or 1000 nm, 
as the definition of NPs varies [119,120]. They can be classified into different classes based 
on their properties, shapes or sizes. On the basis of material composition, the NPs can be 
classified as metal NPs and metal oxide NPs, carbon-based NPs, ceramic NPs, 
semiconductor NPs, polymeric NPs and liquid-based NPs [119]. They are prepared by top-
down or bottom-up syntheses. Due to their size, NPs differ from their bulk material. Various 
physicochemical properties such as large surface area, mechanical strength, optical activity 
and chemical reactivity make NPs unique and suitable applicants for various fields. 
Presently, different metallic nanomaterials and their oxides are being produced using 
copper, zinc, titanium, magnesium, gold, alginate and silver. Nanoparticles can be used for 
diverse purposes, from the field of medicine to the development and manufacturing of  solar 
and oxide fuel batteries for energy storage, electronics, cosmetics or clothes [121]. NPs can 
play very prominent role in environmental technology [122]. Presently, polymeric NPs are 
one of the most studied strategies for nanomedicine [123,124] and mesoporous silica 
nanoparticles have drawn the attention in domain of drug delivery for curing various 
diseases including cancer [125]. 
2.5.1. Nanoparticles (NPs) with antibacterial effect: Copper NPs 
 Numerous studies have confirmed that several NPs possess antibacterial property 
[126]. Apart from widely used silver (Ag) NPs, there are others such as titanium dioxide 
(TiO2), gold (Au), silica (SiO2), copper (Cu)/ copper oxide (CuO), magnesium oxide (MgO) 
and zinc oxide (ZnO) that have been reported to exhibit good biocidal activity [31,127]. Silver 
in various forms (metallic silver, silver salts and colloidal silver) has been used as an 
effective antibacterial agent for many centuries.  In modern medicine, silver NPs are being 
applied widely although bacterial resistance to antibiotics has been extensively discussed in 
the literature. It is reported that bacteria may develop resistance to widely used silver NPs 
[128]. In this context, alternative NPs also started to be explored against drug-resistant 
pathogenic bacteria [129]. In recent times, Copper and copper based (alloy) NPs are being 
popular for the antibacterial efficacy [130].  
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 The methods of synthesizing Cu NPs can be classified into five major categories 
namely: chemical treatment, electrochemical synthesis, photochemical method, 
sonochemical technique and thermal treatment. Moreover, some other sophisticated 
techniques (e.g. laser application) have also been reported recently [131].  
 Mechanism of antibacterial activity of Cu NPs to micro-organisms involves several 
processes, such as displacement of essential metals from their native binding sites or 
through ligand interactions. Toxicity towards microorganisms also results from changes in 
the conformational structure of nucleic acids and proteins which interferes with the oxidative 
phosphorylation and osmotic balance. Despite the several possible mechanisms, copper’s 
initial site of action is thought to be at the plasma membrane as high concentrations lead to a 
rapid decline in membrane integrity, changing its permeability. Copper ions are the active 
agent able to either kill or inhibit the growth of micro-organisms by several processes. The 
copper free radicals can disrupt the cell membrane and release ions to enable interaction 
with proteins and DNA molecules inside the bacteria cell [130]. The mechanisms associated 
with toxicity of copper NPs as summarized in Figure 3. 
 
Figure 3: Different mechanisms associated with the toxicity of copper against bacterial cells [130]. 
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 Furthermore, the exposure of the human skin to the nanoparticles involves the risk of 
their interactions and serious consequences of deterioration in health. The investigation of 
toxicity on human dermal fibroblast showed that the toxicity depends on the concentration of 
NPs and at lower concentration, NPs appeared to be non-cytotoxic [132]. 
 A few studies have been focused on the Cu NP coated biomaterials to investigate the 
antimicrobial activity. The major procedures for Cu NP coatings on materials were physical 
deposition [59,133,134] and radiation induced deposition [58]. Cu NPs are gaining popularity 
in biomedicine due to its potential as effective antibacterial agent.  
2.5.2. Mesoporous silica nanoparticles (MSNs) for drug delivery systems  
 Mesoporous materials are defined by IUPAC as materials with pore sizes between 2 
to 50 nm [135]. Mesoporous materials belong to the nanoporous material family having pore 
size of the materials less than 100 nm. The microporous (pore size less than 2 nm) and 
macroporous (pore size more than 50 nm) materials also come under the classification of 
nanoporous materials.  Mesoporous silica nanoparticles (MSNs) are among the best known 
and most widely used porous materials. In 1968, Stöber et al. first discovered an effective 
method for the synthesis of monodispersed silica particles. The templating method has been 
widely applied to prepare mesoporous silicas. The innovative strategies of MSNs have made 
the structured materials (e.g. disordered, wormhole-like, hexagonal, cubic, and lamellar 
mesophases) possible with various morphologies (e.g. spheres, hollow spheres, fibers, 
tubules, gyroids, helical fibers, crystals and many hierarchical structures), and dimensions 
(nanometer to centimeter) by controlling the reaction conditions (such as reaction 
temperature, pH value, surfactants concentration, silica sources etc.) [136]. These new 
architectures with high surface area, tunable pore sizes, large pore volumes enable 
mesoporous silica for diverse applications in catalysis, sorption, separations, sensing, optics, 
drug delivery etc. [135]. The surfactant micelle-templated mesoporous silica materials are 
mainly classified as: mobil crystalline materials - MCM-41/ 48/ 50, Santa Barbara amorphous 
type materials - SBA-15/ 16, Michigan State University materials - MSU, Korean Advanced 
Institute of Science and Technology material – KIT-1/ 6, plugged hexagonal templated silica 
- PHTS, mesostructured cellular foam - MCF and FSM-16 [135,137].  
 The mesoporous material MCM-41 was first proposed for a drug delivery system by 
Vallet-Regi et al. in 2007. Biocompatible MSN-based controlled release systems have been 
demonstrated to be able to deliver different guest molecules (drugs) [137]. With the rapid 
development of silica-based drug delivery systems over the past decades, the use of pure 
22 
 
mesoporous silica suffers from limitations such as targeted drug delivery mechanisms’ study, 
drug kinetics marker in pharmacological research, and track/evaluate the efficiency of the 
drug release in disease diagnosis and therapy. Therefore, functionalized mesoporous silica 
materials with luminescence or magnetism have been emerged with time [138]. The smart 
combination of different functional groups with MSNs has been investigated for the 
development of multifunctional medical platforms aiming simultaneous targeted delivery, fast 
diagnosis, and efficient therapy [125,138,139]. Very recently, the redox responsive 
mesoporous organosilica nanoparticles containing disulfide (S–S) bridges have been 
developed with higher efficacy for drug delivery system [140].  Therefore, more researches 
are being attracted for exploring new possibilities for MSN application in drug delivery. 
2.6. Aim and Objective of the Thesis 
 Surface modification of polymers has been made possible by various approaches as 
have been discussed earlier. In case of PET chemical surface functionalization, mostly 
aminolysis and hydrolysis have been used as ester bonds are available on PET surface. For 
both the methods corrosion rate is high and therefore, the material may lose its mechanical 
strength which plays very crucial role in biomaterials. Although the cleavage of ester by 
Grignard reagent is very common in general organic chemistry, PET modification has not 
been explored using Grignard reagent as a major chemical. In the first section, we have 
explored the new possibility of surface functionalization on PET using Grignard reagents. 
The non-corrosive modification of PET has been desirable that can exhibit bacterial 
adhesion and biofilm resistance with biocompatibility.  
 Being a common choice for biomaterial, different techniques of Nylon surface 
modification have been investigated. As already discussed, PEG immobilization on 
biomaterials’ surface is a popular concept to impart antifouling property to the surface that 
can efficiently resist bacterial adhesion. Tethering PEG on Nylon or polyamide surface 
needs either complex multi-step chemical treatments or expensive physical treatment like 
plasma treatment. The second section of the thesis has been dedicated to the easy, but 
efficient surface reduction of Nylon 6, followed by grafting PEG covalently via lithiation. The 
antibacterial efficacy as well as bacterial adhesion resistance has been thoroughly 
investigated. The cytocompatibility has been measured to confirm the efficiency of the 
modified Nylon 6 as a biomaterial. The N-alkylation of reduced Nylon 6 has also been 
explored as a model reaction for further possibilities of tuning surface by different other 
desired molecules/ functional groups.  
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  The preparation of Cu NPs is not always an easy task because of their high 
reactivity towards oxidation and the tendency to agglomerate. There are many procedures 
for Cu NP synthesis, whereas the easy and reproducible reduction method has been applied 
here to obtain Cu NPs. The characteristics (including shape and size) of the NPs have been 
investigated. The main aim for Cu NP synthesis was to explore the possibility of Cu NP 
physisorption on grafted Nylon 6 surface for better antibacterial efficacy compared to PEG 
grafted Nylon 6. 
 The last section of the thesis has described the MSN syntheses done with the aid of 
carefully tested procedures recently published. Five well characterized MSNs (MCM-41, 
MCM-48, SBA-15, PHTS and MCF) have been obtained and their application in drug 
(dopamine) delivery profile examined. The goal of this section was to compare the efficiency 

















 PET fabric, with the thickness of 100 µm, was supplied by Silk and Progress, CZ. 
PET foil, having 150 µm of thickness, was supplied by TENOLANVR (IA 0001), Fatra, a.s., 
CZ. Nylon 6 film (thickness of 15 µm), was supplied by Goodfellow Cambridge Ltd., 
(Huntingdon, UK). The Grignard reagents — methylmagnesium bromide (3.0 M CH3MgBr), 
butylmagnesium chloride (2.0 M C4H9MgCl), hexylmagnesium bromide (2.0 M C6H13MgBr), 
octylmagnesium bromide (2.0 M C8H17MgBr), dodecylmagnesium bromide (1.0 M 
C12H25MgBr) all in diethyl ether and octadecylmagnesium chloride (0.5 M C18H37MgCl) in 
tetrahydrofuran (THF) were obtained from Sigma-Aldrich Co., CZ. Diethyl ether (99.7%), 
methanol (99.8%) and hexane (99.9%) were supplied by PENTA Ltd., CZ. Borane-
Tetrahydrofuran complex (1 M, BH3-THF), potassium tert-butoxide (≥98%, t-BuOK), benzyl 
chloride (99%, C6H5CH2Cl), benzophenone (≥99%, C13H10O), N,N′-disuccinimidyl carbonate 
(≥95%, DSC), 5-(dimethylamino)naphthalene-1-sulfonyl chloride/ dansyl chloride (≥99%, 
DNSC/  C12H12ClNO2S), poly(ethylene glycol) methyl ether tosylate (MW = 2000 g/mol, H3C-
PEG-OTs), polyethylene glycol (MW = 1450 g/mol, PEG), n-butyllithium (2.5 M in hexane, n-
BuLi), tert-butyllithium (1.7 M in hexane, t-BuLi), N,N-diisopropylethylamine (≥99%), 4-
(dimethylamino) pyridine (≥98%) and sodium (cubes, contains mineral oil, 99.9% trace metal 
basis; Na) were obtained from Sigma-Aldrich Co., CZ. Solvents tetrahydrofuran (99.95% 
THF), dimethyl sulfoxide (99% DMSO), acetone (99.5%), ethanol (96%), ethanol (absolute), 
2-propanol (99.8%), concentrated hydrochloric acid (35% HCl) and ammonia (22.7%) were 
purchased from Lach:Ner, s.r.o., CZ. Sodium hydroxide (NaOH), calcium hydride (CaH2) and 
calcium chloride (CaCl2) were supplied by PENTA Ltd. CZ. Dry DMSO (anhydrous, ≥99.9%) 
were supplied by Sigma-Aldrich Co., CZ. All unmodified and modified sample washings were 
performed by deionized water. All the chemicals and reagents were used directly without any 
further purification, except diethyl ether and THF. 4 Å molecular sieves (pellets, 3.2 mm 
diameter, Sigma-Aldrich, CZ) were used as drying agent for collection of dry diethyl ether 
after distillation.   
 Copper(II) chloride dihydrate (99.999%, CuCl2.2H2O), Sodium borohydride (99%, 
NaBH4), sodium dodecyl sulphate (≥99%, SDS), hexadecyltrimethylammonium bromide 
((≥99%, CTAB), tetraethyl orthosilicate (98%, TEOS), Fumed silica (powder, 0.2 – 0.3 µm 
average particle size, SiO2), poly(ethylene glycol)-block-poly(propylene glycol)-block-
poly(ethylene glycol) – known as P123 (Mw = 5800 g/ mol), 1,12-dibromododecane (≥96%), 
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N,N-dimethyl hexadecylamine (≥95%, GC) and mesitylene (98%) were supplied by Sigma 
Aldrich Co., CZ. Tetraethylammonium hydroxide (25% in water, TEAOH) and pyridine 
(99.5%, extra dry, over molecular sieves) were purchased form ACROS organics, Belgium. 
Ammonium fluoride (p.a., NH4F) was supplied by Lach:Ner, s.r.o., CZ (99.2%). Milli-Q water 
was used for nanoparticle synthesis and washings. 3-(3,4-dihydroxyphenyl)-L-alanine 
(>98%, L-DOPA) was purchased from TCI EUROPA N.V., Belgium. Liquid nitrogen (N2) was 
obtained from Linde (99.999% purity). 
 For biofilm test on PET surfaces, brain Heart Infusion (BHI) Agar supplied by Fluka 
CZ, D-glucose monohydrate G.R., Lach:ner CZ. Ethanol (96%) by PENTA Ltd., crystal violet 
dye C25N3H30CI, Lach:ner CZ. Staphylococcus aureus CCM - 2260; Escherichia coli CCM - 
2024; methicillin-resistant Staphylococcus aureus (MRSA) CCM - 4223; Pseudomonas 
aeruginosa - CCM 1959 (according to ALE-G18, CSNI, collection of microorganisms from 
Masaryk University Brno, CZ) were used for the biofilm tests. The following bacterial strains 
were used to test antibacterial activity and adhesion behaviours of bacteria on the pure and 
functionalized Nylon 6 sample surfaces; Gram positive bacterial strain Staphylococcus 
aureus, CCM 3953 and Gram negative bacterial strain Pseudomonas aeruginosa, CCM 
3955. Soyabean Casein Didest Medium: HIMEDIA®REF, Plate Count Agar without Dextrose 
(BIORAD a.s., CZ) and sterile physiological solution (6 % NaCl) were used for bacterial 
inoculums preparation. Globular protein Bovine Serum Albumin (BSA, Sigma-Aldrich, CZ) 
was used as support for Staphylococcus aureus better proliferation (0.15 g BSA into 100 ml 
6 % NaCl solution). 
 Cell experiments were performed using 3T3 clone A31 mouse fibroblast cell line. 
Dulbecco’s Modified Eagle’s Medium (DMEM), penicillin/streptomycin antibiotic mixture and 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were supplied by Sigma-
Aldrich Co., CZ. Fetal bovine serum (Biosera, France) and new born calf serum (GibcoVR, 
Thermo Fisher Scientific, CZ) were used as protein supplements. Positive (PM-A) and 
negative (RM-C) cytotoxicity controls were supplied by Hatano Research Institute, FDSC, 
Japan. Staining of cell nuclei and cytoplasm was performed using 3,3’ 
dihexyloxacarbocyanine iodide (DiOC6(3)), Triton X-100 and propidium iodide (PI) supplied 




3.2.1. Surface modification techniques 
3.2.1.1. Preparation of the samples and solvents 
 Both fabric (density = 65.4 g/m2; thickness = 100 µm) and PET foil (density = 211.4 
g/m2; thickness = 150 µm) were cut into pieces (size 5 × 5 cm2). These samples were 
washed three times with acetone and then three times with hexane using sonicating bath 5 
mins each time to remove all impurities. Finally, the samples were dried in desiccator using 
vacuum pump for 5 h.   
 Nylon 6 films (size 6 cm × 6 cm), were thoroughly rinsed with water, ethanol, 2-
propanol, acetone, THF and hexane in sonicating bath for 3 mins per solvent. The washed 
samples were dried at 50 °C/ 3 h in vacuum and stored in desiccator over silica gel until 
used. 
 Diethyl ether (500 ml) was distilled for 3 h in presence of 12 g metallic sodium, under 
the argon atmosphere. The dry diethyl ether was stored with molecular sieves under inert 
atmosphere.  
 Tetrahydrofuran (THF; 1.5 l) was first stirred for 2 days with 5 g calcium hydride 
powder (CaH2) at room temperature (r.t.); 500 rpm, sealing the neck of flask with anhydrous 
(anhy.) calcium chloride (CaCl2) cap. THF was distilled under the argon atmosphere and 
collected over argon. In the second step, 24 g benzophenone (C13H10O) and 10 g sodium 
(Na) were added to the distilled THF and stirred overnight at r.t.; 500 rpm under inert 
condition, until the solvent turned violet in colour. Anhy. THF was prepared by distillation of it 
again and freshly prepared anhy. THF was used for all the required reactions. 
3.2.1.2. Chemical modification of PET surface 
 A series of Grignard reagents such as CH3MgBr, C4H9MgCl, C6H13MgBr, C8H17MgBr, 
C12H25MgBr and C18H37MgCl (with various numbers of carbons in alkyl groups) were used for 
modification of PET fabric and foil. 60 ml of 0.1 M Grignard reagent in anhydrous diethyl 
ether was added to 250 ml 3-necked round bottom flask containing PET foil sample and a 
magnetic stir bar. The flask was attached to Schlenk line to provide argon to the system. The 
reaction mixture was stirred under inert condition at r.t. (20°C); 200 rpm for 1, 2, 3, 4, and 5 
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h respectively. After each reaction, the modified PET sample was washed thoroughly with 
diethyl ether, methanol, 0.01 M hydrochloric acid, and finally three times with distilled water, 
taking 80 ml of each washing solution. The sonicating water bath (K230HTDP 3L variable 
power ultrasonic bath ultrasonic cleaner) was employed for cleaning the surface efficiently. 
Washed samples were dried under the vacuum in the desiccator. The modified samples 
were named after the alkyl groups introduced to the surface: PET–CH3, PET–C4H9, PET–
C6H13, PET–C8H17, PET–C12H25 and PET–C18H37 respectively.  
 PET samples were allowed to react with C18H37MgCl in dry diethyl ether at various 
concentrations (0.1 M, 0.5 M and 1.0 M) for 1 h and 140 h respectively under argon 
environment controlled by Schlenk line. It was useful to study the effect of Grignard reagent 
reaction time and concentration on PET surface modification. 
 All the modified samples (size 5 cm × 5 cm) were cut into 4 pieces (each size 2.5 cm 
× 2.5 cm) for the further tests.  
3.2.1.3. Fluorescence labelling of PET surface 
 A standard procedure was followed for the fluorescence labelling [141]. Virgin PET 
and all Grignard reagent (3 h) modified foils (size 2.5 cm × 2.5 cm; PET–CH3, PET–C4H9, 
PET–C6H13, PET–C8H17, PET–C12H25 and PET–C18H37) were stirred at r.t./ 150 rpm in a 
solution of 10 mg dansyl chloride (C12H12ClNO2S) in 5 ml dry pyridine. After 3 h, the samples 
were removed and washed with 10 ml ethanol for 4 h, using a mechanical shaker. Again the 
samples were washed overnight with acetone. The reaction and washing processes were 
carried out under dark condition. For calibration, the above mentioned procedure was 
followed by using pure PET foils. All samples were air-dried before the fluorescence intensity 
measurement.  
3.2.1.4. Reduction of Nylon 6 with BH3-THF 
 The amide functional groups present in Nylon 6 were reduced to secondary amine 
according to procedure described by Herrera-Alonso et al. [112]. Dry THF (50 ml) was 
introduced into the Schlenk flask (250 ml) kept under argon atmosphere, containing 1 
weighed dry sample (~ 90 mg). BH3-THF solution [8 ml, 1 M (8 mmol)] was added at 0°C 
with stirring (150 rpm). Reaction mixture was stirred for 1 hour at r.t. and overnight at 50 °C. 
After cooling down to r.t., the reduced samples were washed with THF, 1 M HCl, deionized 
water, 1 M NaOH, deionized water, THF, ethanol, acetone and hexane, each by sonication 
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for 3 minutes. The samples were dried at 50 °C/ 3 h in vacuum and stored in the desiccator 
until further modification. For long-time storage, 1 M NaOH solution was skipped and 
modified Nylon 6 was stored as ammonium chloride salt prepared by HCl washing. Reduced 
samples have been referred as Nylon 6-NH.  
 All the modified Nylon 6 samples (size 6 cm × 6 cm) were cut into 2 cm × 2 cm size 
pieces for the further tests.  
3.2.1.5. N-alkylation with benzyl chloride (C6H5CH2Cl ) 
 t-BuOK (0.056 g, 0.5 mmol) was introduced into the round bottom flask (100 ml), kept 
under dry argon, containing 5 weighed Nylon 6-NH samples (~ 50 mg). Dry DMSO (20 ml) 
was added into the flask and stirred at 150 rpm/ r.t./ 1 h. Subsequently, the second solution 
containing dry DMSO (10 ml) and benzyl chloride (0.115 ml, 1 mmol), premixed and 
equilibrated at r.t./ 1 h, was dropped into the reaction mixture. The reaction was allowed to 
proceed for 1 h and 3 h respectively. The modified samples were rinsed thoroughly in the 
sonicating bath with DMSO, deionized water, ethanol, THF, acetone and hexane; then dried 
at 50 °C/ 3 h in vacuum and stored in the desiccator. Modified samples have been referred 
as Nylon 6-NCH2Ph.  
3.2.1.6. Grafting of Nylon 6-NH with H3C-PEG-OTs 
 Dry THF (50 ml) was added into the Schlenk flask (250 ml) containing 10 Nylon 6-NH 
(~ 100 mg) samples. Then t-BuLi [1.7 M; 0.6 ml (~ 1 equiv.), 1 ml (~ 1.7 equiv.), 2 ml (~ 3.3 
equiv.)] was introduced into the flask. n-BuLi [2.5 M; 0.4 ml (~ 1 equiv.), 7ml (~ 1.7 equiv.), 
1.3 ml (~ 3.3 equiv.)] can also be used instead of t-BuLi (1.7 M) for the same reaction. The 
lithiation was allowed to occur at r.t./ 250 rpm in different time intervals (2 h, 4 h, 6 h and 24 
h). Into the second Schlenk flask, containing H3C-PEG-OTs (2 g, 1 mmol) was added dry 
THF (50 ml) and the mixture was stirred at r.t./ 700 rpm/ 1 h. After lithiation, the solution of 
remaining t-BuLi was carefully removed from the first flask via syringe and washed twice with 
dry THF under argon flow. Subsequently, H3C-PEG-OTs solution was added into the first 
flask containing lithiated Nylon 6-NH samples and was allowed to react at r.t./ 250 rpm in 
different time intervals (2 h, 4 h, 6 h, 15 h). The grafted samples were washed thoroughly 
with THF, ethanol, acetone and hexane; then dried at r.t./ 5 h in the vacuum and stored in 
the desiccator. Modified samples have been referred as Nylon 6-N-PEG-CH3. 
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3.2.1.7. Tethering of PEG on Nylon 6-NH surface by conjugating DSC 
 A verified procedure was followed for the following conjugation reaction [142]. 5 ml 
N,N-diisopropylethylamine and 0.3843 g DSC (1.5 mmol) were stirred in 60 ml dry acetone 
at r.t./ 500 rpm/ 1 h. This suspension was added into the Schlenk flask (250 ml) containing 5 
Nylon 6-NH samples and stir bar under argon and stirred at r.t./ 200 rpm/ 3 h.  The reaction 
media was removed carefully via syringe   and washed twice with dry acetone in the closed 
system. Meanwhile, Polyethylene glycol (2.9 g, 2 mmol PEG) was dried at r.t. for 2 h in cold 
trap using liquid nitrogen (N2). 35 ml of dry acetone was added to 100 ml round bottom flask 
containing dry PEG and a sir bar, under inert atmosphere and stirred at r.t./ 400 rpm for 2 h. 
In another flask, 1.466 g of 4-(dimethylamino) pyridine (12 mmol) was dissolved in 20 ml dry 
acetone and stirred at r.t./ 200 rpm for 1 h. First, the PEG solution was added to the washed 
Nylon 6-NH samples after reaction with DSC. Then, 4-(dimethylamino) pyridine solution was 
introduced, stirred at r.t./ 200 rpm and allowed to react overnight. Finally, the samples were 
removed and rinsed with acetone, ethanol and hexane by sonication; then dried at r.t./ 5 h in 
the vacuum and stored in the desiccator. Modified samples have been referred as Nylon 6-
N-PEG. 
3.2.1.8. Deposition of Cu NPs on grafted Nylon 6 (Nylon 6-N-PEG-CH3) surface 
 4 mg of Copper nanoparticles (Cu NPs, 500 – 900 nm particle size) were dissolved in 
40 ml deionized water under inert atmosphere and introduced to 100 ml Schlenk flask under 
argon containing 4 Nylon 6-N-PEG-CH3 (2 h lithiation, 1 ml t-BuLi) samples and kept the 
samples immersed into the solution overnight at r.t; washed twice with water and twice with 
ethanol using sonicating bath each time for 1 min to remove excess Cu NPs on surface.  
The samples were dried at 45°C/ 4 h in the vacuum and stored in the desiccator. Cu NP 
deposited samples have been referred as Nylon 6-N-PEG-CH3-Cu. 
3.2.2. Surface characterization 
3.2.2.1. Water contact angle (WCA) and free surface energy (FSE) analyses 
 The WCAs and FSEs (Kwok-Neumann model) were measured using a portable 
computer-based instrument with special purpose software following ISO 27448:2009 test 
method (See System E, Advex Instruments, CZ). WCA measurement is one of the rapid, 
easy and useful surface analytical techniques. The θ/2 method was used to analyse the 
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profile of sessile drop, assuming the liquid drop to be part of a sphere. WCA values were 
calculated by the following equation (1), 
𝑡𝑎𝑛 (𝜃/2) =  ℎ/𝑥            (1)  
where, 𝜃 = static contact angle, ℎ = droplet height and 𝑥 = half of the droplet width [143]. 
Contact angle measurements were performed by vertically dispensing 20 droplets (3.5µl/ 
droplet) of deionized water on each sample. The droplets were allowed to equilibrate for 10 
seconds before the measurement. The mean values were taken for plotting the WCA 
histograms including standard deviations (± SD); all the values for each sample were in a 
range of ±5°. The FSEs related to the mean values of WCAs were directly measured by the 
software using Kwok-Neumann model. Neumann and Kwok proposed the following equation 
(2) for the FSE determination of solids by using one liquid [144]. 
𝛾𝐿(1 +  cos 𝜃) = 2√𝛾𝐿 . 𝛾𝑆 [1 − 0.0001057(𝛾𝐿 − 𝛾𝑆)
2]      (2)                      
Where 𝛾𝐿 and 𝛾𝑆 are the FSE of the liquid and solid respectively, 𝜃 is the contact angle. 
Both, 𝛾𝐿 (experimental surface tension) and 𝜃 can be easily determined. The water surface 
tension ( 𝛾𝐿) is a known value at a definite temperature. 
3.2.2.2. Fluorescence intensity assessments 
 Synergy™ HTX Multi-Mode Microplate Reader (BioTek, Germany) with UV-VIS 
absorbance and filter-based fluorescence was used to measure the fluorescence intensity of 
dansylated PET foils. The samples were cut into 1 cm x 1 cm size to fit in the 24 welled cell 
culture plates. The chemically bonded dansyl groups on the surface were determined by 
excitation at 360 nm and emission maximum at 528 nm at the gain of 200.  
3.2.2.3. Scanning electron microscopy (SEM) and atomic force microscopy  
   (AFM) analyses 
 The surface morphology changes were examined by the SEM (ZEISS, Sigma Family, 
Germany). PET fabrics were sputtered with platinum and PET foils were sputtered with gold. 
Subsequently they were viewed as secondary electron images (2 kV). Modified and 
unmodified Nylon 6 samples were sputtered with 2 nm platinum layer, subsequently were 
viewed as secondary electron images (1 kV).  
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 The topography of the pure and modified PET as Well as Nylon 6 films was studied 
in the air at atmospheric pressure with NanoWizard® 3 NanoScience AFM (JPK 
Instruments, Germany). For more accurate scanning, a contact mode with Cantilever 
NANOSENSORSTM PPP-CONTSCR (resonance frequency = 23 kHz; contact force = 0.2 
Nm-1; tip radius <10 nm; tip height 10–15 µm) was used. Sample scans and subsequent 
surface roughness (Ra) evaluation were performed on areas 10 µm x 10 µm and 1 µm x 1 
µm. Obtained data were processed by using the freeware software Gwyddion and JPK Data 
Processing.  
3.2.2.4. X-ray photoelectron spectroscopy (XPS) analyses 
X–ray photoelectron Spectroscopic (XPS) measurements investigating C1s and N1s 
binding energies (eV) before and after Nylon 6 modification were done by a Thermo 
Scientific K-Alpha X-ray Photoelectron Spectrometer (Thermo Fisher Scientific) using a 
monochromatic Al Kα radiation (hγ= 1486.6 eV).  
3.2.2.5. Fourier transform infrared (FT-IR) and Raman spectroscopy analyses 
The Nicolet™ iS™10 FT-IR Spectrometer (Thermo Scientific™, USA) was employed 
for the investigation of modified PET foils and Nylon 6 samples compared to the pure ones. 
The DXR™ Raman Spectrometer (Thermo Scientific™, USA) were used to examine the 
changes in surface composition after the conversion of Nylon 6-NH to Nylon 6-NCH2Ph, due 
to the FT-IR limitations.  
3.2.3. Antibacterial and cell experiments 
3.2.3.1. Biofilm tests of PET 
 A standard procedure was followed to perform biofilm experiments with pure PET, 
PET–CH3 and PET–C12H25 foil samples [145]. Four different pathogenic bacterial strains 
namely; E. coli, S. aureus, methicillin-resistant S. aureus (MRSA), and P. aeruginosa were 
enlivened, inoculated, and cultivated to obtain individual bacterial colonies on the agar. Brain 
heart infusion (BHI) agar was used to prepare solution for bacterial growth (BHI 5.2 g/ 1000 
ml). BHI was dissolved in distilled water and was sterilized in an autoclave for 15 min at 
121°C. After cooling down to 37°C, 10 ml of the solution was added into the sterile container 
and subsequently one colony of chosen bacterial strain was added through inoculating loop. 
The container was vortexed and kept in the thermostat for 24 h at 37°C. After incubation for 
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24 h, samples were immersed into the cultivated solution and whole system was cultivated in 
the thermostat for 72 h. Glucose (1 g/ 50 ml BHI) was added into the solution to prepare 
better nourishing conditions. Samples were removed from the solution and washed twice 
with distilled water, twice with physiological solution and finally kept for 20 min in the 
container with ethanol. Subsequently, samples were washed with distilled water and 
immersed into the containers containing dye solution (crystalline violet 2.5 g/100 ml of 
ethanol mixed with diammonium oxalate 4 g/ 400 ml of distilled water) for 45 min. Marked 
samples were washed with distilled water, dried at room temperature and observed through 
optical microscope Leica DM750. Magnifications 40X (HI Plan 4X/ 0.10 NA, 18.0 mm W.D.) 
and 100X (HI Plan 10X/ 0.25 NA, 12.0 mm W.D) were used. 
3.2.3.2. Antibacterial tests of Nylon 6 
 Antibacterial action assessments were performed in a compliance with 
commonly used standard method CSN EN ISO 6222. Cultivation was done from lyophilized 
bacterial strains that were added into the Soyabean Casein Didest Medium. After cultivation 
in the medium for 48 h/ 37°C, both bacterial strains were re-inoculated on the Plate Count 
Agar without Dextrose. S. aureus culture was cultivated for 48 h and P. aeruginosa for 24 h. 
Both, thus obtained, cultures were used to prepare the bacterial inoculums with initial 
concentration 3.0 x 107 CFU/ ml for the following antibacterial tests. In detail, fresh cultured 
bacteria were added by sterilized loop into 10 ml of sterile physiological solution (6 % NaCl) 
until it reached the required McFarland standard concentration (0.1 McFarland standard 
concentration = 3.0 x 107 CFU/ ml). This concentration is referred further as 100.  
 For convenience, all the Nylon 6 samples were named as follows: sample 1 (S1) - 
pure Nylon 6, sample 2 (S2)  - Nylon 6-NH, sample 3 (S3) - Nylon 6-N-PEG-CH3 (2 h 
lithiation, 0.6 ml t-BuLi), sample 4 (S4) - Nylon 6-N-PEG-CH3 (24 h lithiation, 0.6 ml t-BuLi), 
sample 5 (S5) - Nylon 6-N-PEG-CH3 (2 h lithiation, 1 ml t-BuLi), sample 6 (S6) - Nylon 6-N-
PEG-CH3 (24 h lithiation, 1 ml t-BuLi), sample 7 (S7) - Nylon 6-N-PEG-CH3 (2 h lithiation, 2 
ml t-BuLi) and sample 8 (S8) - Nylon 6-N-PEG-CH3 (24 h lithiation, 2 ml t-BuLi). All the 
samples (2 cm x 2 cm size) were sterilized for 20 minutes by UV A for each bacterial test. 
Subsequently, 50 ml of bacterial inoculum homogenous solution (3.0 x 107 CFU/ ml) was 
added to each sample kept in a 100 ml Fisher bottle. Total 16 sets were prepared, 8 sets 
(samples 1 - 8) with S. aureus and other 8 sets with P. aeruginosa. The bacterial solutions 
were incubated 24 h/ 37 °C.  
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The control tests related to the both bacterial strains were performed directly by 
adding 1 ml of initial and diluted control solution into a Petri dish at required concentration 
(100, 10-1, 10-2, 10-3, 10-4, 10-5, 10-6 and 10-7) to the agar medium. The Petri dishes were 
incubated 48 h/ 37 °C. The grown bacteria were counted after 48 h incubation. Samples 1 - 
8 were tested with the following procedure; 1 ml each of the solution at different 
concentrations (100, 10-1, 10-2, 10-3, 10-4, 10-5, 10-6 and 10-7) was directly used for bacterial 
proliferation in agar medium. In each Petri dish, 1 ml of bacterial solution (with specific 
required concentration already mentioned above) was added and the liquid agar media was 
poured at 37 °C, shaking gently to spread the bacterial solution homogenously in agar. After 
cooling the agar medium to set, all the covered Petri dishes were kept into the incubator 48 
h/ 37 °C. Finally, the grown bacteria were counted. All the tests were repeated twice. 
To examine the bacterial adhesion on the surface of each sample (samples 1 - 8), 
the following procedure was used: each sample incubated in bacterial inoculum (3.0 x 107 
CFU/ ml) for 24 h/ 37 °C was taken out from the inoculum and transferred to 100 ml Fisher 
bottle containing 20 ml sterile physiological solution (6% NaCl). The bottles were shook 
vigorously for 1 h to remove surface adhered bacteria in solution. 1 ml of each solution at 
different concentrations (100, 10-1, 10-2, 10-3, 10-4, 10-5, 10-6 and 10-7) was directly used for 
bacterial proliferation in agar medium into the incubator for 48 h/ 37 °C as mentioned in the 
previous paragraph.  
3.2.3.3. Antibacterial tests of Nylon 6-N-PEG-CH3-Cu 
 The Zone of Inhibition Test (Kirby-Bauer test), a qualitative method was used to 
measure the ability of Nylon 6-N-PEG-CH3-Cu sample (named as sample 9 or S9) to inhibit 
microbial growth (S. aureus and P. aeruginosa). 1 ml of both the bacterial inoculums 
(prepared as mentioned previously) with initial concentration 1 x 107 CFU/ ml, were spread 
over two agar plates separately using sterile swabs, then 2 cm x 2 cm size Nylon 6-N-PEG-
CH3-Cu sample is placed to the centre of the agar plate and incubated at 37°C for 48 h and 
96 h. The bacterial growth-inhibiting effect was determined by the size of inhibition zone 
(clear zone) appeared around the sample. 
 The quantitative antibacterial test procedure was same as the antibacterial test of 
pure and functionalized Nylon 6. 
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3.2.3.4. Cytotoxicity and cell adhesion of pure and modified PET  
Cytotoxicity test 
 Potential cytotoxic effect of the surface modification was evaluated in vitro by test in 
direct contact. The test was performed in compliance with standard ISO 10993–5:2009 
Biological evaluation of medical devices—tests for in vitro cytotoxicity. Before exposure to 
the tested samples (pure PET, PET–CH3 and PET–C12H25 foil), 3T3 fibroblast cells were pre-
cultured under standard conditions up to ~90% confluence. Tested samples and positive and 
negative control were applied to each culture vessel covering exactly one eighth of the cell 
layer surface. Testing of each sample was performed in triplicate. Cell viability was 
evaluated after 24 h of exposure in complete culture media (DMEM, 5% FBS, 5% NBCS, 
ATB) via standard mitochondrial oxidoreductases metabolic activity test. Degree of reduction 
of MTT was determined spectrophotometrically by reading at 570 nm (background 
subtracted at 650 nm). Percentage of viable cells in each vessel was compared to viability of 
blank. In order to reveal potential cytotoxic effect of the surface treatment and distinguish 
possible distorting effect of mechanical damage caused to the cell layer and the effect of the 
original unmodified foil, the metabolic activity was compared to three types of blank. The 
blanks used in this study were unaffected cell control (CC), negative control (NC), and 
untreated PET foil. 
Cell adhesion and proliferation  
 The influence of surface treatment on cell adhesion and proliferation were evaluated 
using the same fibroblastic cell line. Samples (pure PET, PET–CH3 and PET–C12H25 foil) of 1 
× 1 cm2 sizes were fixed to a culture vessel bottom and exposed to cell suspension of 40 × 
103 cells/ml for 24 h. Both, the density of adhered cells and their morphology were 
determined microscopically. After the 24 h of exposure, samples were fixed in methanol and 
stained with propidium iodide (PI) for cell nuclei imaging (red, Ex/ Em = 540/ 608 nm) and 
DiOC6(3) for membrane structures in cytoplasm imaging (green, Ex/ Em = 482/ 501 nm). 
The imaging was carried out on Axio Imager M2 microscope using EC Plan-Neofluor 
objectives 10X, 20X, 40X (Carl Zeiss Tld.). Density of the adhered cells was evaluated 
through cell nuclei count performed on 10 images (magnification 100X) of each sample 
using ImageJ software. For cell morphology evaluation imaging under magnifications 100X, 
200X, and 400X was used. 
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3.2.3.5. Cytotoxicity and cell adhesion of pure and modified Nylon 6 
 Cytotoxicity of extracts   
  Extracts of all types of foils materials were tested according to ISO 10993-5. Prior to 
in vitro experiment, materials (samples 1 - 9) were sterilized by immersion in 70% ethanol for 
30 minutes followed by double washing in phosphate buffer saline (PBS). Mouse 3T3-SA 
fibroblasts (passage 7) were used for cytotoxicity assessment of foils according to ISO 
10993-5. Extracts of the three types of materials in concentrations of 10 mg/ ml and 5 mg/ ml 
were prepared. Materials were put in sterile test tube and soaked in complete media 
(DMEM, 10% FBS, 1% ATB, 1% glutamine). After 24 h of shaking in 37°C (100 rpm), the 
extracts were added to subconfluent layer of fibroblasts seeded in 96 well plates. Two 
concentrations of extracts were tested: 10 mg/ml and 5 mg/ml. Cells in complete media 
served as negative control (NC). Complete media with addition of cytotoxic agent Triton X-
100 was used as positive control (PC). After 24 h of incubation, cell metabolic activity was 
determined by colorimetric MTT assay (n = 12 per each group). Measured absorbance of 
negative control was considered as 100% viability. Recalculated values of cell viability were 
plotted in the graph showing the cytotoxic effect of materials that is determined by viability 
decrease under 70% of control cells. Before performing metabolic MTT tests for the 
samples, cells were also captured by optical microscopy (KRD, NIB-100, CZ) with 
magnification 100X. 
Direct contact cytotoxicity  
 Fibroblasts were seeded in 12 well plates. After reaching subconfluency, tested 
materials (samples 1 – 9) in size of approximately 5 mm x 5 mm were added into the wells (n 
= 4 per each material). After 37°C/ 24 h of incubation, cells were observed by optical 
microscopy and cell metabolic activity was determined as previously by MTT test. The same 
control was used for calculation of cell viability (NC – cells in complete media, PC – cells in 
media + Triton X-100). Before MTT assay, cells were examined microscopically with 
magnification 100X. 
Cell adhesion and proliferation  
 Sterile samples (samples 1 – 8) in size of approximately 2 cm x 2 cm were placed in 
the bottom of 6 well plates and seeded with fibroblasts. After 1 and 7 days of incubation at 
37°C, foils with adhered cells were washed twice in PBS and fixed in 2.5% glutaraldehyde. 
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Then, cells were stained by phalloidin-FITC that binds to actin filaments in the cytoplasm and 
DAPI that visualize cell nuclei in blue. Fluorescence microscope (Nikon ECLIPSE Ti-E/B) 
was used to capture cell spreading (objective 20X). Optical microscope (KRD, NIB-100, Cz) 
with magnification 100X, was also used to observe the cell proliferation on sample surface. 
Cell proliferation was also assessed by SEM (VEGA3, TESCAN, Cz). Samples (1 – 8) were 
fixed and dehydrated by gradually increased ethanol. Then, they were placed on holder, 
coated with gold and analysed using VEGA 3SB Easy probe. 
 Cell viability was measured by metabolic MTT test in the same time periods of 1 and 
7 days after seeding. Tested samples (1 – 8) were transferred into new well plate and 
incubated at 37°C for 3 h with MTT solution. Similarly, control tissue culture plastic (TCP) 
was also analysed. The formed violet crystals were dissolved in acidic isopropanol and 
resulting absorbance (570 - 650 nm) was measured. 
3.2.4. Nanoparticles preparation, characterization and application 
3.2.4.1. Synthesis of copper nanoparticles (Cu NPs) 
 The synthesis was carried out in aqueous phase and inert condition using a reducing 
agent [146]. 100 ml 0.03 M copper (II) chloride dihydrate (CuCl2. 2H2O) solution was added 
to 100 ml 0.1 M sodium dodecyl sulphate (SDS) solution (pH = 7) under inert condition in a 
250 ml round bottom flask containing stir bar. 43 ml 0.12 M sodium borohydride (NaBH4) 
solution was added to the flask under a continuous flow of argon. The solution was turned to 
dark brown immediately after NaBH4 addition and stirred at r.t./ 800 rpm until the 
characteristic brick red colour of Cu NPs appeared. CuNPs were separated from the 
aqueous solution by centrifugation at 12,000 rpm for 45 mins and washed twice with ethanol. 
Then dried at r.t./ 4 h in the vacuum and stored under argon. The synthesized Cu NPs were 
used in section 3.2.1.7. for making Nylon 6-N-PEG-CH3-Cu sample. 
Yield = ~170 mg  
3.2.4.2. Characterization techniques for Cu NPs 
 Dynamic light scattering (DLS) is a well-established technique for measuring the size 
of nanoparticles. Malvern Zetasizer Nano Series (Malvern Instrument Ltd., UK), particle size 
range 0.3nm - 10µm, was used to determine the Cu NPs size immediately after the 
reduction of CuCl2 to zero-valent Cu and at other various intervals (1 h, 3 h and 24 h, 1 
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month). 2 µl reaction solution was transferred to cuvette (capacity = 2.5 µl) and the particle 
size was measured. 
FT-IR spectra (Nicolet™ iS™10; Thermo Scientific™, USA) of pure SDS and SDS-
capped Cu NPs were recorded to determine the binding interactions of SDS with zero-valent 
Cu NPs. 
 Size distribution and shape homogeneity of Cu NPs were examined by SEM (ZEISS, 
Sigma Family, Germany) images. Samples were prepared by taking small quantities of Cu 
NPs dispersed in deionised water. Then the solution was dropped on carbon-coated copper 
grid and kept in the freezer at -80° for 15 mins. The grid was immediately transferred to 
lyophilizer (FreeZone 2.5 Liter Benchtop Freeze Dry System, Labconco, Canada) and dried 
under vacuum (3 mbar at -52°C) to ensure complete removal of water. Image J software was 
used to measure the nanoparticle size. 
UV-VIS spectroscopy (HACH® DR 6000, wavelength range: 190 – 1100 nm, 
scanning speed: 900 nm/ min) was used for preliminary estimation of Cu NPs synthesis 
immediately after the reaction and at other time intervals (15 mins, 30 mins, 1 h and 2 h).  
3.2.4.3. Synthesis of mesoporous silica (SiO2) nanoparticles (MSNs) 
 The following MSNs (mobil crystalline material – MCM, Santa Barbara amorphous – 
SBA, Plugged hexagonal templated silica – PHTS and mesostructured cellular foam – MCF) 
were prepared by the selected procedures described in various verified literatures [135,147]. 
MCM-41 (from fumed silica)  
 6.2 g CTAB was added to 40.4 g Milli-Q water in a 250 ml round bottom flask 
containing stir bar and stirred vigorously at 45 °C until dissolved completely. The solution 
was cooled down to room temperature. Then, 10 g of TEAOH (20%) solution was added to it 
and stirred for 5 mins at 500 rpm. After that, 4.1 g fumed silica was added and stirred at 
70°C for 2 h, followed by further 24 h of vigorous stirring at r.t. The viscous solution was 
heated to 130°C for 48 h, sealing the flask tightly. After the heat treatment, the solution was 
filtered. The solid was washed with 150ml deionized water and transferred into an autoclave 
and some fresh water was added until the solid was just covered.  It was heated a second 
time to130°C for 72 h. After hydrothermal treatment, the solid was filtered using vacuum 
pump, washed 3 times with 25 ml water and dried. The product was crushed into fine 
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powders for calcination at 550°C during 6 h with a heating rate of 1° C/min in ambient 
atmosphere. The final white product was cooled down slowly and stored. The obtained 
product has been referred as MCM-41(FS). 
Yield = 3.2 g 
MCM-41 (spherical) 
 3.75 g CTAB was added to 70.71 g Milli-Q water in a 250 ml round bottom flask 
containing stir bar and stirred at 45°C until complete dissolution. The solution was cooled 
down to room temperature.  25.74 g NH3 (25%) and 90 g ethanol were added to it and 
stirred at 500 rpm for 30 mins.  7.05 g TEOS was introduced dropwise stirring the solution 
for 3 h at 500 rpm and then for 12 h at 300 rpm /25°C. The solution was filtrated under 
vacuum and the solid was subsequently washed with 150 ml distilled water and thereafter 
with 150 ml methanol. The solid was heated at 90°C for 20 h. The post-synthesis treatment 
was achieved by calcination of the product at 550°C during 5 h with a heating rate of 1°C/ 
min in ambient atmosphere. The product was cooled down slowly and stored. The obtained 
product has been named as MCM-41(S). 
Yield = 2 g 
MCM-41 (Highly ordered MSNs) 
 121 ml of NH3.H2O (22.7%) was mixed with 116.5 ml of Milli-Q water to form a 
homogeneous solution in a round bottom flask (250 ml) containing stir bar. 1.0 g of CTAB 
was added into this solution and stirred vigorously at 500 rpm/ 45 °C until a homogeneous 
solution is obtained. When CTAB was completely dissolved, the solution was cooled down to 
room temperature. Then, 5 ml of TEOS was added to the surfactant solution in one injection 
and stirred at r.t./ 500 rpm for 2 h. Precipitation occurred very quickly, and that indicated the 
hydrolysis of TEOS. After 2 h of stirring, the resulting precipitate was collected using vacuum 
filtration. The solid was washed with copious amounts of distilled water until neutralized and 
dried at 90 °C overnight. The dried solid was crushed into fine powders and transferred into 
a crucible for calcination at 550 °C in 6 h with a heating rate of 1°C/ min in ambient 
atmosphere. The final product was cooled down slowly, stored and named as MCM-41(HO). 




(A) Synthesis of gemini 16-12-16 surfactant: 
 12 g of 1.12-dibromododecane and 25.5 ml of N,N-dimethylhexadecylamine were 
added to 50 ml acetone in round bottom flask (250 ml) containing stir bar and attached to an 
air cooler. The temperature was increased to 65°C until refluxing started.  Refluxing was 
continued at 500 rpm for 24 h. The gemini surfactant started to crystallize after 12 h. The 
system was cooled down. Then, the surfactant crystals were filtered and washed with 
acetone. The gemini was recrystallized in a beaker with acetone. The final product was 
collected by vacuum filtration and washed twice with acetone. The gemini surfactant is dried 
at room temperature in ambient conditions. 
Yield of gemini 16-12-16 surfactant = ~20 g 
(B) Synthesis of MCM-48 
120 ml of Milli-Q water and 0.6922 g NaOH were added to 5.7734 g gemini 16-12-16 
surfactant in a round bottom flask (250 ml) containing stir bar. The solution was stirred at r.t./ 
700 rpm until gemini is dissolved. 4 g fumed silica was added and stirred for 2 h. The sealed 
flask was aged in an oven at 130°C during 3 days. After heat treatment, the flask was 
brought to r.t. and the product was filtered and washed with 100 ml water. The solid was 
crushed further washed 4 times with deionized water using centrifuge for 5 mins each time at 
10,000 rpm. The residue was transferred to an autoclave and 60 ml of deionized water was 
added. The autoclave was heated in an oven at 130°C for 1 day. After heat treatment, the 
product was recovered by vacuum filtration and further washed thrice with 150 ml distilled 
water; then dried at ambient condition. The final product was obtained after the solid was 
calcined at 550°C during 6 h with a heating rate of 1°C/ min in ambient atmosphere. The 
product was cooled down slowly and stored. 
Yield = 3 g 
SBA-15 
 4 g of P123 was added to 130 ml of Milli-Q water and 21 ml of HCl (35%) in round 
bottom flask (250 ml) containing stir bar. The solution was stirred at r.t./ 800 rpm/ 3 h until 
complete dissolution. 9.14 ml of TEOS was introduced and continued stirring overnight at 
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45°C. Ageing of the white precipitate was carried out for 24 h at 80°C, in the sealed flask 
without stirring. The system was cooled down and the product was recovered by vacuum 
filtration, washed thrice with 50 ml of distilled water and then dried overnight at 80°C. The 
final product was calcined at 550°C during 6 h with a heating rate of 1°C/ min in ambient 
atmosphere. Cooling down was occurred slowly and collected. 
Yield = 2.8 g 
PHTS (Plugged hexagonal templated silica) 
 4 g of P123 was added to 130 ml of Milli-Q water and 21 ml of HCl (35%) in round 
bottom flask (250 ml) containing stir bar. The solution was stirred at r.t./ 800 rpm/ 3 h until 
complete dissolution. 16 ml of TEOS was introduced and continued stirring during overnight 
at 60°C. Ageing of the white precipitate was carried out for 24 h at 80°C, in the flask sealed. 
The system was cooled down to r.t. and the product was collected by vacuum filtration. Then 
it was washed thrice with 50 ml of distilled water and then dried overnight at 80°C under 
ambient atmosphere. The final product was calcined at 550°C during 6 h with a heating rate 
of 1°C/ min in ambient atmosphere. The product was cooled down and collected. 
Yield = 4.2 g 
MCF (mesostructured cellular foam) 
 4 g of P123 and 21 ml of HCl (35%) were added to 130 ml of Milli-Q water; stirred at 
r.t./ 700 rpm, in a 250 ml round bottom flask with stir bar, until the surfactant was dissolved. 
0.0467 g of NH4F and 4.6 ml of mesitylene were introduced into the flask. The temperature 
was raised to 40°C and stirring was continued at 800 rpm for 1 h. Then, 9.14 ml of TEOS 
was added and stirred for another 20 h at 40°C. The mixture was transferred to an autoclave 
and kept at 100°C for 24 h. After the heat treatment, the autoclave was quenched to r.t.. 
Product recovery was accomplished by vacuum filtration, followed by washing the solid 
thrice with 50 ml of water and dried at ambient atmosphere. The final product was collected 
after calcination at 550°C during 6 h in ambient atmosphere with a heating rate of 1°C/ min. 
The product was cooled down slowly. 
Yield = 2.3 g  
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3.2.4.4. Characterization techniques: BET and SEM 
 The gas sorption analyser (Autosorb® iQ, Quantachrome Instruments) was employed 
to examine the surface areas and pore size distributions for MSNs. The surface areas and 
pore size distributions were calculated using ASiQwin software based on adsorption-
desorption isotherms. The pristine samples were degassed at 300°C for 3 h. Then N2 
adsorption and desorption isotherms were measured at the temperature of -196 °C. 
Multipoint BET (Brunauer–Emmett–Teller) analysis was applied for the total surface area 
calculation. Models of DFT (Density Functional Theory) were used to determine pore size 
distribution and also compared to relatively old BJH (Barret-Joyner-Halenda) model. 
 Size distribution and shape homogeneity of Cu NPs were examined by SEM 
(ZEISS, Sigma Family, Germany) images. Samples were prepared by taking small quantities 
of MSNs dispersed in distilled water. Then the solution was dropped on carbon-coated 
copper grid and dried under vacuum to ensure the complete removal of the solvent. MSNs 
were sputtered with 2 nm platinum layer, subsequently were viewed as secondary electron 
images (2 kV). 
3.2.4.5. Drug loading on and releasing from MSNs 
Preparation of L-DOPA solution 
 50 ml Milli-Q water was added to 50 mg L-DOPA in an Erlenmeyer flask (100 ml) 
covered with aluminium foil and sonicated during 1 h at r.t. for complete dissolution. This 
solution was used for drug loading as well as for calibration. 
Drug loading 
 The drug L-DOPA was loaded by soaking 10 mg of silica in 1 mg/ ml of L-DOPA 
solution (in Milli-Q water) for 2 h, 4 h, 6 h, 15 h and 24 h. The drug-loaded MSNs were 
stored into the refrigerator (4°C) covered with aluminium foil as L-DOPA solution is very 
sensitive towards heat and light. The drug-loaded samples were centrifuged at 10,000 rpm 
for 10 mins and the clear solution above the precipitate was collected for examining the 
loading profiles for each of the samples. The L-DOPA loaded solid samples were collected 




Drug release  
 100 mg of the L-DOPA loaded samples were dispersed in 10 ml of phosphate buffer 
solution with pH 7.2 (PBS, K2HPO4 and KH2PO4) and kept at 37°C using an incubator in 
order to simulate the body temperature during 15 mins, 30 mins, 1 h, 2h and 3 h. A higher 
amount of drug was expected to be released into the intestine at pH range 7–8 [148]. 
3.2.4.6. Monitoring of drug loading and releasing by UV method 
 Both the drug loading and releasing profiles for each of the samples were determined 
by monitoring the absorbance change using the UV-VIS spectrophotometer (HACH® DR 
6000, wavelength range: 190 – 1100 nm, scanning speed: 900 nm/ min). The calibration 
curve (for drug loading profile) was prepared by measuring the absorbance at various 
suitable concentrations of L-DOPA solution in water and absorption peaks were recorded at 
290 nm for L-DOPA. Similarly, for drug releasing profile, the calibration curve was also 













4. RESULTS AND DISCUSSION 
4.1. PET 
4.1.1. PET surface modification 
4.1.1.1. General mechanism of Grignard reagent reaction with esters 
 Esters react with Grignard reagents (R–Mg–X; R = alkyl group, X = halogen such as 
Cl, Br or I) to yield tertiary alcohols in which two of the substituents (–R) bonded to the 
hydroxyl-bearing carbon always come from the Grignard reagent. Grignard reaction involves 
addition of a carbanion nucleophile (R:– +MgX) [149]. The general mechanism of Grignard 
reagent reactions are depicted below in Figure 4 using ethyl acetate (CH3COOEt where Et 
represents ethyl group) as a model ester. The given mechanism is also applicable for 
polyesters such as PET. 
 
Figure 4: Mechanism of Grignard reagent reaction with ester (ethyl acetate). 
4.1.1.2. Ester bond cleavage of PET 
 The PET fabric and foil surface functionalization with hydroxyl and alkyl groups was 
achieved by chemical reaction under inert condition that involved the cleavage of ester bond 
on the surface with Grignard reagents. The modification by Grignard reagents with various 
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alkyl groups having different C chain lengths (–CH3, –C4H9, –C6H13, –C8H17, –C12H25 and –
C18H37), represented by R, is shown in Scheme 1. The C atoms of carboxylate groups on 
the PET surface were attacked by the Grignard reagents, resulting in the elimination of 
ethylene glycol [150].  
 
Scheme 1: PET surface functionalization by Grignard reagents in dry diethyl ether (R = –CH3, –C4H9, 
–C6H13, –C8H17, –C12H25 and –C18H37).  
4.1.1.3. Dansyl chloride (DNSC) coupling  
 Dansyl chloride (DNSC) is used in analytical chemistry for fluorescence labelling of 
certain functional groups, such as hydroxyl group (–OH), carboxylic acid group (–COOH) 
and extensively for primary and secondary amines. The dansylation of hydroxyl group (–OH) 
by coupling creates a fluorescent derivative that can be detected by UV-VIS spectroscopy 
with great sensitivity [151]. The DNSC coupling was applied to confirm the presence of –OH 
groups on the PET foil surfaces treated with different Grignard reagents. Scheme 2 shows 




Scheme 2: Dansyl chloride coupling with hydroxyl groups (–OH) on modified PET foils (R = –CH3, –
C4H9, –C6H13, –C8H17, –C12H25 and –C18H37). 
4.1.2. Characterization 
4.1.2.1. WCA and FSE analyses of pure and modified PET samples 
 The mean WCAs for Grignard reagent modified PET samples (both fabric and foil) 
were decreased after the reaction with CH3MgBr compared to the pure PET. The WCAs 
increased gradually in case of binding longer alkyl groups (–C4H9, –C6H13, –C8H17, –C12H25 
and –C18H37). The measured WCAs of PET–C6H13 were almost equal to the virgin PET. 
PET–C12H25 and PET–C18H37 fabric and foil samples exhibited similar increase in WCAs. In 
case of all modified PET fabrics, the samples prepared after 3 – 4 h reactions showed 
maximum modifications in terms of WCAs compared to 1 h, 2 h and 5 h reactions (Figure 5 
a). On the other hand, for modified PET foils, the WCAs were almost same within 1 to 5 h of 
reaction times. The time of the treatment with Grignard reagent was not correlated to WCAs 
(Figure 5 b). PET–C18H37 foils with various concentrations (0.1 M, 0.5 M and 1.0 M) and 
reaction times (1 h and 140 h) did not show significant alteration of WCAs (Figure 5 c). The 
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variations of WCAs for PET fabric as well as foil with different Grignard reagents and 
reaction times are compared in Figure 5 (a, b, c). By the observation of WCAs before and 
after modification of PET, it can be inferred that 0.1 M Grignard reagent under 3 h reaction 
time was sufficient for maximum surface modification at room temperature. The alkyl groups 
were responsible for the hydrophobicity enhancement on the modified PET surface with the 
increase in number of carbon atoms in alkyl groups present in the Grignard reagents. On the 
other hand, the presence of hydroxyl groups responsible for enhancing hydrophilicity.  PET 
surface treated with CH3MgBr (1C) had the lowest value of WCAs compared to pure PET 
and the other modified PET samples since the polar hydroxyl groups (–OH) on the surface 
dominated and finally increased the net hydrophilicity of PET fabric and foil. The PET 
samples treated with C4H9MgCl (4C), C6H13MgBr (6C), C8H17MgBr (8C), C12H25MgBr (12C) 
and C18H37MgCl (18C) increased the hydrophobicity on the surface gradually as the longer 
alkyl chains caused the hindrance to polar hydroxyl groups (-OH). Therefore, hydrophobicity 
of PET–C6H13 was almost equal to the virgin PET. PET–C12H25 and PET–C18H37 exhibited 
maximum hydrophobicity as both of them had long alkyl chains (12C and 18C respectively) 



































Figure 5: The mean WCA measurements comparing virgin and modified PET fabrics a); virgin and 
modified PET foils b) and PET–C18H37 foils prepared by different C18H37MgCl (G. R.) concentrations 
with various reaction time. 
 The FSE plays an important role on bacterial adhesion and therefore the parameter 
is considered to be very important in surface characterization [26]. The FSEs of samples 
modified with CH3MgBr and C4H9MgCl increased compared to the virgin PET. PET-C6H13 
showed nearly equal FSE values as pure PET. Moreover, FSEs values gradually decreased 
after treating with C8H17MgBr. C12H25MgBr and C18H37MgCl. The variations of FSEs with 
different Grignard reagents and reaction times are shown in Figure 6 (a, b) compare to pure 
PET foil and fabric. The effect of reaction time and Grignard reagent (C18H37MgCl) 











































































































Figure 6: The FSE measurements of virgin and modified PET fabrics a); virgin and modified PET foils 
b) and PET–C18H37 foils prepared by different C18H37MgCl (G. R.) concentrations with various reaction 
time. 
4.1.2.2. Fluorescence intensity assessments of functionalized PET foils 
 The analysis of a thin layer chemical composition on the polymer surface is hardly 
possible by the conventional tools for chemical structural analysis, such as NMR and FT-IR 
spectroscopy. In that case, fluorescence spectrometry has been reported to be a powerful 
complementary tool for the surface chemical analysis by coupling dye [141]. Virgin PET, 
calibrated PET (DNSC treated) and Grignard reagent modified (3 h) PET foils, examined by 
fluorescence intensity test, revealed that the virgin PET had no reaction with DNSC as the 
pure PET and DNSC treated PET showed almost same fluorescence intensity, whereas all 
the functionalized  PET foils exhibited much higher fluorescence intensity compared to pure 
PET. It was interesting to notice that PET–CH3 showed maximum fluorescence intensity as 
expected due to the presence of –OH groups with shortest alkyl chain (–CH3). On the other 
hand, the fluorescence intensity consistently decreased most probably due to the steric 
hindrance caused by other bulky alkyl chains. PET–C18H37 displayed minimum fluorescence 
intensity due to the presence of octadecyl (–C18H37) group that caused maximum hindrance 
over –OH groups on modified PET surface and much less activation with DNSC. Figure 7 






















Figure 7: The fluorescence intensity measurements for pure and different Grignard reagent modified 
PET foils. 
4.1.2.3. SEM analyses  
 Changes in the surface morphology of all prepared samples were observed by SEM 
(Figure 8 and 9) and subsequently by AFM (Figure 7 and 8).  
 The surface modifications of both PET fabric (Figure 8) and foil (Figure 9) were 
successfully analysed by SEM. The better results were obtained through the reaction with 
Grignard reagents having higher number of carbon chains starting from C6H13MgBr. The 
best modification was achieved by C12H25MgBr/ 3 h for both types of samples. Coating was 
rarely visible on PET–CH3/ 3 h surface (Figure 8 b and 9 b) whereas PET–C6H13/ 3 h and 
PET–C12H25/ 3 h samples apparently showed the coating on the surface of both fabric and 
foil (Figure 8 c, d and 9 c, d). Moreover, a very little corrosion and several pores were 
identified in the coatings (Figure 8 c, d and 9 b, c, d). Most probably the porosity occurred 
due to the thickness of the coating, and/ or due to the worse adhesion of the coating to the 
PET surface. We suggest that all prepared coatings had different thickness in the different 
parts of the samples. In SEM images analyses, similar results were observed for both fabric 
and foil modified PET samples. Moreover, AFM was used as another method confirming the 




Figure 8: The SEM images of the virgin PET fibres a); PET fibres modified with CH3MgBr/ 3 h b); PET 





Figure 9: The SEM images of the virgin PET foil a); PET foil modified with CH3MgBr/ 3 h b); PET foil 
modified with C6H13MgBr/ 3 h c) and PET foil modified with C12H25MgBr/ 3 h d). 
4.1.2.4. AFM analyses  
The modification of the PET foils was analysed through the changes in the surface 
roughness (Ra) compared to the unmodified one. The increase in the surface roughness of 
the modified PET foil was significantly proved by AFM analysis (Table 1) with obtained Ra 
values. Figure 10 (a, b, c) and 11 (a, b) showed the changes in the surface topography 
before and after the modifications. At first, surface topography of an unmodified PET 
samples (size 9 mm x 6 mm) were studied. The same samples were subsequently kept in 15 
ml of diethyl ether for 3 h under argon atmosphere and measured again, in the same area, to 
examine the swelling effect. Finally, these samples were allowed to react with 15 ml of 
previously mentioned Grignard reagents (0.1M) with different alkyl groups in diethyl ether in 
argon atmosphere for 3 h. The changes in the surface topography of PET foil treated with 
the Grignard reagents were analysed through AFM micrographs again in the same area as 
in the previous two experiments. It was proved that, surface roughness (Ra) was increased 
significantly for the Grignard reagent with long alkyl chain (8C, 12C and 18C) treated PET 
foils compared to the swelled (in diethyl ether) and unmodified samples whereas, short alkyl 
chain (1C, 4C and 6C) modified PET foils did not demonstrate any noticeable difference in 
Ra values. The comparative study of Ra values to the virgin, swelled and chemically 
modified PET foils (PET–C8H17, PET–C12H25 and PET–C18H37) are introduced in the Table 
1, where two different areas (10 µm x 10 µm and 1 µm x 1 µm) were compared. Figure 10 
(a, b, c) shows the AFM micrographs obtained from 1 µm x 1 µm area comparing virgin, 
solvated and modified PET–C12H25. Figure 11 (a, b) shows the significant differences in 
surface topography between PET–CH3 (1 C) and PET–C18H37 (18 C) within 10 µm x 10 µm 
surface area.  
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Table 1: The surface roughness (Ra) values before and after modification of PET foils. 
 
               Samples 
 
Surface 
   Area 
 
Surface roughness (Ra) values 
 
PET foil  
(virgin) 









(10 × 10) µm2 6.69 nm 10.09 nm 10.65 nm 18.05 nm 24.30 nm 
(1 × 1) µm2 1.17 nm 1.53 nm 2.11 nm 2.72 nm 10.29 nm 
 
 
Figure 10: The AFM images (1 x 1) µm2 of unmodified PET foil a); PET foil swelled in diethyl ether for 




Figure 11: The AFM images (10 x 10) µm2 of PET foil modified with CH3MgBr for 3 h a) and PET foil 
modified with C18H37MgCl for 3 h b).  
4.1.2.5. FT-IR analyses 
 All pure and functionalized PET foils were characterized by FTIR and the 
measurement was performed in two different spots. In Figure 12, the difference in stretching 
vibrations of PET–CH3 and PET–C12H25 samples can be clearly seen when compared to the 
unmodified PET (i.e. 2848 cm-1, 2862 cm-1, 2918 cm-1 and 2952 cm-1). The asymmetric and 
symmetric stretching vibrations of C–H bonds for immobilized alkyl chains (–CH3 and –
C12H25) were visible on Grignard reagent modified samples. Interestingly, the PET–C12H25 
sample showed stronger absorption band than PET–CH3 sample. Pure PET demonstrated 





Figure 12: FTIR spectra showing the characteristic peaks of the stretching vibrations of pure PET and 
alkyl chains (–CH3 and –C12H25) covalently linked to the surface after modifications.  
4.1.3. Analyses of antibacterial activity and cell experiments 
4.1.3.1. Biofilm assessment of pure and functionalized PET 
 Biofilm experiments were performed with four pathogenic bacterial strains on the 
pure PET, PET-CH3 and PET–C12H25 foils. Due to the smooth surface of foils, compare to 
the rough PET fabrics, the foils only were used for biofilm experiments. Firstly, Gram 
negative bacteria Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa) 
were tested, followed by Gram positive cocci bacteria and biofilm positive bacterial strains 
Staphylococcus aureus (S. aureus) and methicillin-resistant Staphylococcus aureus (MRSA). 
 PET–CH3 and PET–C12H25 foils were effective against growth of the S. aureus, 
MRSA and E. coli biofilms. Gram negative E. coli is rod shaped bacterium proved to be 
biofilm negative bacterial strain for both the modified PET foils (Figures 13 b1 and c1). 
Surprisingly, unmodified PET sample also didn´t indicate biofilm growth (Figure 13 a1). This 
effect can be attributed to the surface morphology of the tested PET foils. E. coli is well 
known as a bacterial strain, which usually doesn´t have tendency to adhere to the smooth 
surfaces and form the uniform biofilm there, therefore only individual colonies can be formed 
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on such a surface. The same effect was observed in all three tested samples (PET, PET–
CH3 and PET–C12H25). P. aeruginosa was another tested pathogenic bacterial strain. P. 
aeruginosa is a common Gram negative, rod-shaped bacterium and biofilm positive bacterial 
strain. Thin biofilm layer formed with P. aeruginosa was observed in the several parts of the 
both modified PET samples (Figures 13 b2 and c2), although the pure PET foil was more 
vulnerable towards biofilm growth (Figures 13 a2). In this case we suppose, that 
modification through -CH3 and -C12H25 functional groups was not efficient enough to resist 
biofilm formation. 
 Figures 14 b1 (sample modified with –CH3) and 14 c1 (sample modified with –C12H25) 
demonstrated very significant elimination of the S. aureus biofilm, compare to the unmodified 
sample in Figure 14 a1, where the formation of polysaccharide matrix caused by S. aureus 
was clearly visible. It is worth to mention that, the similar results were obtained for MRSA, 
which belongs to the same bacterial class as S. aureus is. Moreover, modified PET samples 
(Figures 14 b2 and c2) tested against S. aureus contained only a few individual bacterial 
colonies on their surface compared to the intensely covered unmodified PET sample (Figure 
14 a2).  
 
Figure 13: Biofilm tests with E. coli for pure PET a1); PET–CH3 b1); PET–C12H25 c1) and P. 




Figure 14: Biofilm tests with S. aureus for pure PET a1); PET–CH3 b1); PET–C12H25 c1) and MRSA 
for pure PET a2); PET–CH3 b2); PET–C12H25 c2) [Magnification 40X]. 
 The overall experimental results showed that the biofilm inhibition was higher than 
90% for both modified PET foils, implemented through Grignard reagents, against S. aureus, 
MRSA and E. coli, compared to the 40% inhibition of P. aeruginosa. Samples modified with 
–CH3 functional groups (PET–CH3) show in all experiments slightly better results. These 
samples contained less bacterial colonies compared to the –C12H25 modified samples (PET–
C12H25). However, the difference was only in the units of bacterial colonies, but was 
observed in all tested and compared samples. 
 Bacterial adhesion on a surface is very complex and dynamic process. Functional 
groups on the material surface play important roles in hydrophilicity as well as bacterial 
adhesion on the surface. Hydroxyl (–OH) and methyl (–CH3) groups are very common 
functional groups in biomaterials as these groups are also present in protein structures [26]. 
The materials’ FSEs that were calculated by using the WCAs, significantly influenced the 
bacterial attachment to the material surface and thus are considered to be one of the major 
parameters [152]. Wide scientific studies reported that FSE between 23 and 30 mJ/ m2 was 
related to the lowest bacterial adhesion [153]. Both modified PET foils had FSE between 31 
and 37 mJ/ m2 (Figure 6 b), yet the modified PET had effective functional groups to reduce 
bacterial attachment to the PET surface.  
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4.1.3.2. Cytocompatibility assessment of pure and functionalized PET 
 Polymeric materials that come in contact with the human body are expected to 
perform their intended functions without resulting in any adverse effect to a patient. Potential 
adverse effects can range from short-term (acute) to long-term (chronic) adverse effects to 
the body. From this point of view, polymeric medical devices are typically subject to 
biocompatibility testing to assess the interaction between a device and tissue, cells or body 
fluids of the patient. Tests performed within this study are related primarily to the acute 
toxicity evaluation.  
Table 2: The results of cytotoxicity test (cell viability calculated as percentage of metabolic activity of 
the cell population) in direct contact performed on 3T3 fibroblasts in vitro 
SAMPLES ABBREVIATIONS 










Cell control CC 110.80 7.97 113.25 8.15 
 
Positive control PC 8.15 1.59 8.33 1.63 
 
Negative control NC 100.00 9.33 102.21 9.54 
 
Unmodified foil PET foil 97.84 8.83 100.00 9.03 
 
Methyl-treated foil PET-CH3 (3h) 96.82 10.36 98.96 10.59 
 
Dodecyl-treated foil PET-C12H25 (3h) 93.19 6.92 95.24 7.07 
 
 The results showed that both types of the modified samples reached viability of the 
exposed cells higher than 70% compared to the cell control (CC) as a blank (Figure 15). 
Methyl-treated foil PET–CH3 (3 h) reached viability (87.38%) of CC and the dodecyl-treated 
foil PET–C12H25 (3 h) reached viability (84.10%) of CC. According to these results, both the 
samples were proved to be cytocompatible. The possible influence of mechanical damage 
was evaluated using certain PET foil. Using negative control (NC) as a blank for viability 
calculation the effect of mechanical damage of the cell layer was proven resulting in about 
10% decrease of cell viability per sample. Using the unmodified PET foil as a blank for the 
viability calculation it was shown that both the surface treatments performed have a minimal 
impact on the 3T3 cells viability. The PET–CH3 (3 h) reached viability (98.96%) of pure PET 
foil and the PET–C12H25 (3 h) reached viability (95.24%) of unmodified PET foil. Complete 




Figure 15: The results of the cytotoxicity test compared to cell control (CC) as a blank. Line (-) on 
70% of cell viability represents limit established as the minimal value for biocompatibility assessment. 
4.1.3.3. Cell adhesion of pure and functionalized PET 
 Both tested samples exhibited decreased cell adhesion in comparison to pure PET 
foil (Figure 16). Better adhesion by the 3T3 cells/ cm2 of PET–CH3 (mean value = 12254) in 
comparison to the PET–C12H25 surface (mean value = 10593) can be attributed to the 
different surface energy and morphology. Application of the dodecyl group modification led 
to decrease of the adhered cells/ cm2 of the surface. In the both cases, modified surfaces 
contain hydrophilic –OH groups together with hydrophobic –CH3 or –C12H25 groups. 
Therefore, the accessibility of the -OH groups the most probably played an important role in 
the adhesion of the cells together with the resulted biocompatibility of both the functionalized 
surfaces (PET–CH3 and PET–C12H25). For PET–CH3 hydroxyl (–OH) groups were accessible 
easily, whereas long dodecyl groups on the surface of PET-C12H25 samples could cover the 
hydrophilic hydroxyl groups and led to reduced protein adsorption and cell adhesion. 
Mentioned conclusions are supported by the morphology of adhered cells analysed by 
fluorescence microscopic images (Figure 17). It was evident that the surface modification 
not only exhibited reduction of the cell adhesion but also affected morphology of the 3T3 
cells in terms of shape and size. In the case of the pure PET foil, well spread cells were 
observed (Figure 17 a1 – a3). In both cases of modifications, the surface treatment led to 






















most apparent on the PET–C12H25 surface (Figure 17 c1 – c3) and can be attributed to the 
previously mentioned changed in surface chemistry and morphology.  
 
Figure 16: Results of cell adhesion test showing number of cells adhered to the surface of tested 
samples in 24 h. Results (MEAN ± S.D.) are given in number of 3T3 cells/ cm
2 






























Figure 17: Results of fluorescent microscopic analysis showing morphology of 3T3 cells after 24 
hours of adhesion to the pure PET foil a1 - a3); PET–CH3 (3 h) foil b1 – b3)  and PET–C12H25 (3 h) foil 
c1 – c3)  [Magnifications 100X, 200X and 400X]. 
 A number of polymer surface parameters; such as morphology, roughness, WCAs or 
hydrophilicity/ hydrophobicity, FSEs, along with surface chemical composition; are 
responsible for biocompatibility and cell adhesion [154,155]. Moreover, no significant 
correlation has been found between the WCAs as well as wettability parameters or the FSE 
parameters and cell proliferation characteristics in spite of various investigations by many 
researchers [154]. No clear correlation between FSEs/ WCAs results and cell adhesion were 





4.2.    Nylon 6  
4.2.1. Nylon 6 surface modification 
4.2.1.1. General mechanisms for amides: reduction followed by N-alkylation 
and grafting   
 The mechanisms for reduction of amide to amine, N-alkylation of amine using t-
BuOK for amine group (–NH2 or >NH) activation and grafting of PEG–CH3 via lithiation are 
shown in Figure 18 (a, b, c). In case of amide reduction to amine (Figure 18 a), the Lewis 
basic carbonyl groups in amides form complex with the empty p orbital of the Lewis acidic 
borane (BH3). Hydride transfer is then occurred from anionic boron to electrophilic carbon. 
The resulting tetrahedral intermediates collapse to an iminium ion that is reduced again by 
the borane [156]. Here, a model amide (R–CO–NH2) has been used to explain the reduction 
mechanism. Figures 18 b and c depict the common nucleophilic substitution reactions that 
take place with amines for N-alkylation and grafting respectively. Moreover, t-BuOK and t-
BuLi activate the amine group for N-alkylation and grafting respectively. For both the 






Figure 18: The general mechanisms for reduction of amide to amine a); N-alkylation of amine using t-
BuOK b) and grafting of PEG–CH3 via lithiation c). 
4.2.1.2. Reduction, N-alkylation and grafting of Nylon 6 
 The reduction of amide (–CONH–) functional groups on Nylon 6 surface to secondary 
amine (–CH2NH–) on Nylon 6-NH using borane-tetrahydrofuran (BH3-THF) complex, 
followed by N-alkylation reaction of Nylon 6-NH with benzyl chloride (C6H5CH2Cl) in 
presence of potassium t-BuOK forming Nylon 6-NCH2Ph are shown in Scheme 3 a. The 
Nylon 6-NH surface grafted with H3C-PEG-OTs via lithiation is proposed on the right hand 
side of the Scheme 3 a. The N-alkylation can be considered as the conversion confirmation 
of Nylon 6 to Nylon 6-NH. Nylon 6-NH, washed with 1 M HCl, prohibits any side reaction 
during modified samples storage. Scheme 3 b shows the pictorial representation of Nylon 6 





Scheme 3: Conversion of Nylon 6 into Nylon 6-NH, followed by N-alkylation to form Nylon 6-NCH2Ph 
and grafting on Nylon 6-NH by H3C-PEG-OTs to form Nylon 6-N-PEG-CH3 a); Pictorial representation 
of Nylon 6 surface modification b). 
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4.2.1.3. Tethering of PEG on Nylon 6-NH surface by conjugating DSC 
 N,N′-disuccinimidyl carbonate (DSC) is the smallest homo-bifunctional N-
Hydroxysuccinimide (NHS) ester crosslinking reagent that is highly reactive toward 
nucleophiles [142]. DSC can activate both hydroxyl (–OH) and amine (–NH2 and >NH) 
groups. DSC undergoes rapid hydrolysis in aqueous solution and therefore anhydrous 
organic solvents are needed to be used during the treatments. Scheme 4 shows the two-
step preparation protocol for immobilizing PEG on the Nylon 6-NH surface by activating the 
secondary amine groups on the surface first via DSC. The amine activated surface is named 
as Nylon 6-N-SC and the PEG tethered final surface is Nylon 6-N-PEG. 
 
Scheme 4: Preparation of PEG tethered Nylon 6-NH surface (Nylon 6-N-PEG) via DSC. 
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4.2.1.4. Deposition of Cu NPs on grafted Nylon 6 (Nylon 6-N-PEG-CH3) surface  
 The Cu NPs stabilized with SDS were physically adsorbed on the Nylon 6-N-PEG-
CH3 (2 h lithiation, 1 ml t-BuLi) surface (Scheme 5). SDS could be highly solvated in pure 
water and therefore, it provided steric hindrance between SDS capped Cu NPs dispersed in 
an aqueous phase [157]. This quality allowed for the production of stable Cu NP dispersions 
with a strong affinity to a broad range of surface immobilized with polar poly(ethylene glycol) 
methyl ether (PEG-CH3) that allowed the nanoparticles to physisorb onto a range of 
interfaces . 
 





4.2.2.1. WCA and FSE analyses of pure and modified Nylon 6 samples 
 The WCAs measurements related to the unmodified and modified films are 
presented in Figure 19 (a, b). The significant increase in WCAs mean by 11° after Nylon 6 
films modification into Nylon 6-NH indicated the surface alteration [158]. Further Nylon 6-NH 
conversion into Nylon 6-NCH2Ph increased the mean WCAs by 11° and 12° for 1 h and 3 h 
reactions respectively due to the benzyl group insertion to the Nylon 6-NH surface. DSC 
activated Nylon 6-N-PEG surface (mean WCA ~ 52°) made the Nylon 6-NH films more 
hydrophilic by tethering PEG chains [57]. The deposition of Cu NPs made Nylon 6-N-PEG-
CH3-Cu surface significantly hydrophobic and the WCA was increased to 124° (Figure 19 
a). The mean WCAs decreased significantly after grafting with H3C-PEG-OTs. The WCA 
differences between Nylon 6-NH and grafted Nylon 6-N-PEG-CH3 films, after 2 h lithiation 
using 0.6 ml, 1 ml and 2 ml t-BuLi, were 37°, 36° and 22° respectively. This observation 
claimed that the modified Nylon 6 films become more hydrophilic, a property due to the 
ability of PEG chains to engage in hydrogen bond interaction with surrounding water 
molecules [159]. An interesting point was that, the H3C-PEG-OTs grafted Nylon 6-NH films 
via 4 h, 6 h and 24 h lithiation become less hydrophilic than H3C-PEG-OTs grafted Nylon 6-
NH via 2 h lithiation with a particular t-BuLi concentration. Nylon 6-N-PEG-CH3 films, which 
were obtained by different reaction times, using 0.6 ml and 2 ml t-BuLi, were correlated 
significantly with respect to t-BuLi concentration and lithiation reaction time. Although Nylon 
6-N-PEG-CH3 films procured by using 1 ml t-BuLi showed more hydrophilicity than expected 
with the lithiation time increase (Figure 19 b). The hydrophilicity decrease together with the 
reaction time and t-BuLi concentration increase may be explained by the grafting intensity 
(due to the higher surface activation) that was provided by SEM analyses (Figure 21 e, f, g). 
The WCAs did not depend on grafting reaction time (2 h, 4 h, 6 h and 15 h) with H3C-PEG-
OTs. In a compliance with several analyses we concluded that, 2 h reaction time was 
sufficient for the grafting. It is worth to be mentioned that, Nylon 6 polymer swelling may 





Figure 19: The mean WCA data for pure and modified Nylon 6 films a) and Nylon 6-N-PEG-CH3 after 
grafting at various conditions b). 
 The FSEs decreased consecutively after Nylon 6 reduction to Nylon 6-NH and further 
modification to Nylon 6-NCH2Ph (1 h, 3 h) as the mean WCAs increased after modification of 
Nylon 6. There was a significant change in FSE value after tethering PEG on Nylon 6-NH 
surface via DSC to form Nylon 6-N-PEG (Figure 20 a). As the PEG immobilization made the 
surface more hydrophilic, the FSE was enhanced significantly (33.36 mJ/ m2 to 52.26 mJ/ 
m2). Again, the FSE was reduced (10.26 mJ/ m2) in case of hydrophobic Nylon 6-N-PEG-
CH3-Cu due to the presence of Cu NPs on the surface. The grafted Nylon 6-N-PEG-CH3 


































































hydrophilicity of the grafted surface depends on the fact how densely the surface is packed 
with PEG-CH3 chains. Terminal -CH3 groups increase seems to be the reason for 
decreasing the hydrophilicity. As a consequence, the FSEs increased significantly in case of 
Nylon 6-N-PEG-CH3 compared to Nylon 6-NH; but vary with the alteration of t-BuLi 
concentration and reaction time. The FSE values of grafted Nylon 6-N-PEG-CH3 are shown 
in Figure 20 b.  
 
 
Figure 20: The FSE values for pure and modified Nylon 6 films a) and Nylon 6-N-PEG-CH3 after 
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4.2.2.2. SEM analyses  
 Surface morphologies observed by SEM images for unmodified and modified 
samples, revealed that the surfaces of Nylon 6 and Nylon 6-NCH2Ph samples are uneven 
compared to Nylon 6-NH (Figure 21 a, b, c), which were further confirmed by AFM analyses 
(Table 3). SEM analysis clearly demonstrated that Nylon 6-NCH2Ph surface has formed a 
layer on the Nylon 6-NH surface (Figure 21 c). The uniform layer was seen for the PEG 
tethered Nylon 6-N-PEG (Figure 21 d). The image of Nylon 6-N-PEG-CH3-Cu surface 
confirmed the presence of Cu NPs. The nanoparticles, prepared by our standard protocol, 
were distributed on the surface and the sizes were ranged from 500 – 900 nm. In case of 
H3C-PEG-OTs grafting on Nylon 6-NH, the SEM images supported successful grafting as 
the formed layers can be identified on the Nylon 6-NH surfaces (Figure 21 e, f, g). The 
Nylon 6-NH films, modified with 2 lithiation reaction by the different t-BuLi concentrations 
(0.6 ml, 1 ml and 2 ml) were compared with aim to show significant changes occurring on the 
surface. Moreover, Nylon 6-N-PEG-CH3 (2 h lithiation, 2 ml t-BuLi) showed denser grafting 
layer on the surface than Nylon 6-N-PEG-CH3 (2 h lithiation, 0.6 ml t-BuLi) and Nylon 6-N-
PEG-CH3 (2 h lithiation, 1 ml t-BuLi). No significant differences were noticed in the SEM 
images of Nylon 6-N-PEG-CH3 samples produced by various lithiation time keeping the t-







Figure 21: Nylon 6 a); Nylon 6-NH b); Nylon 6-NCH2Ph (3 h) c); Nylon 6-N-PEG d); Nylon 6-N-PEG-
CH3/ 2 h lithiation, 0.6 ml t-BuLi e); Nylon 6-N-PEG-CH3/ 2 h lithiation, 1 ml t-BuLi f); Nylon 6-N-PEG-
CH3/ 2 h lithiation, 2 ml t-BuLi g) and Nylon 6-N-PEG-CH3-Cu h). 
4.2.2.3. AFM analyses  
 The surface roughness (Ra) values of two different areas (1 µm x 1 µm and 10 µm x 
10 µm) obtained for unmodified Nylon 6 and modified Nylon 6-NH, Nylon 6-NCH2Ph (1 h, 3 
h), Nylon 6-N-PEG-CH3 (2 h lithiation, 0.6 ml t-BuLi and 24 h lithiation, 2 ml t-BuLi), Nylon 6-
N-PEG, Nylon 6-N-PEG-CH3-Cu indicated significant changes after chemical modifications 
72 
 
and deposition of Cu NPs. We suggest that the notably high Ra values for Nylon 6-NCH2Ph 
are the results related to the corrosion which occurred on the surface due to the reaction 
with strong base t-BuOK before N-alkylation. The obtained Ra values are presented in the 
Table 3. The Ra value decreased noticeably after Nylon 6 reduction. On the contrary, N-
alkylation and H3C-PEG-OTs grafting on Nylon 6-NH surface have increased the surface 
roughness. The Cu NP deposition on Nylon 6-N-PEG-CH3 significantly increased the surface 
roughness of Nylon 6-N-PEG-CH3-Cu as expected. Nylon 6-N-PEG film demonstrated more 
surface roughness than Nylon 6-N-PEG-CH3 films. Measured Ra values also supported the 
obtained SEM images (Figure 21, a - h) and confirmed the Nylon 6 films modifications. 





(1 × 1) µm2 (10 × 10) µm2 
Nylon 6 5.1 nm 34.8 nm 
Nylon 6-NH 1.3 nm 7.2 nm 
Nylon 6-NCH2Ph (1 h) 22.3 nm 138 nm 
Nylon 6-NCH2Ph (3 h) 21.1 nm 187.6 nm 
Nylon 6-N-PEG-CH3 (2 h lithiation, 
0.6 ml t-BuLi) 
1.3 nm 12.8 nm 
Nylon 6-N-PEG-CH3 (24 h 
lithiation, 2 ml t-BuLi) 
1.1 nm 12.7 nm 
Nylon 6-N-PEG 3.79 nm 18.42 nm 
Nylon 6-N-PEG-CH3-Cu 11.83 nm 30.37 nm 
 
 AFM micrographs (3D) of pure Nylon 6 and modified ones are displayed for the 
visual understanding related to surface topography changes in (10 x 10) µm2 surface area 




Figure 22: AFM analyses of 3D images related to Nylon 6 a); Nylon 6-NCH2Ph/ 3 h b); Nylon 6-N-
PEG c) and Nylon 6-N-PEG-CH3-Cu d). 
 AFM images related to Nylon 6-NH and Nylon 6-N-PEG-CH3 grafted samples 2D 
(Figures 23 a, b. c) and 3D (Figures 24 a, b, c) (10 x 10) µm2 size were investigated to 
compare Nylon 6-NH with other two grafted samples. Obtained images showed significant 
changes in the surface roughness between Nylon 6-NH and Nylon 6-N-PEG-CH3 [111]. 
Apparently, the differences in surface morphologies of the Nylon 6-N-PEG-CH3 films have 
not been seen for two different lithiation times with two different concentrations (2 h lithiation, 
0.6 ml t-BuLi and 24 h lithiation, 2 ml t-BuLi), but the SEM micrographs and WCA differences 
support the denser grafting via 4 h lithiation reaction than 2 h lithiation.  
 
Figure 23: 2D (10×10) µm
2
 AFM images showing Nylon 6-NH a); Nylon 6-N-PEG-CH3/ 2 h lithiation, 




Figure 24: 3D (10×10) µm
2
 AFM images of Nylon 6-NH a); Nylon 6-N-PEG-CH3/ 2 h lithiation, 0.6 ml 
t-BuLi b) and Nylon 6-N-PEG-CH3/ 24 h lithiation, 2 ml t-BuLi c). 
4.2.2.4. XPS analyses of pure and modified Nylon 6 
 The shifts in the binding energy of high resolution C1s and N1s spectra, comparing 
Nylon 6 and Nylon 6-NH (Figure 25 a, b), clearly indicated the amide functional groups 
reduction on Nylon 6 surface to secondary amines after modification with BH3-THF. The C1s 
peak had binding energy at 288.5 eV for Nylon 6 due to the carbonyl group (C=O) presence 
in amide and C-C peak was observed at 285 eV. After reduction, only C-C peak coming from 
C1s (285 eV) was observed (Figure 25 a), these results indicated the amine groups 
formation on the reduced Nylon 6 surface [111]. The slight shift observed in N1s peak from 
399 eV to lower binding energy occurred due to the BH3-THF reduction and may be the 
result related to the imine (C=N) groups formation on the Nylon 6-NH surface (Figure 25 b). 
Noticeably, the strong satellite peaks belonging to the N1s spectra indicate occurring 
reduction on the Nylon 6 surface. The benzyl group (-CH2Ph) introduction to Nylon 6-NH via 
N-alkylation for 1 and 3 h was successfully confirmed by N1s spectra showing very weak 
satellite peaks which are significantly different from Nylon 6-NH (Figure 25 d). The small C1s 
peak visible at 288.5 eV in case of Nylon 6-NCH2Ph samples may indicate the presence of 




Figure 25: Nylon 6 surface modification to Nylon 6-NH: C1s spectra a); N1s spectra b); benzyl groups 
immobilization via 1 and 3 h reactions forming Nylon 6-NCH2Ph: C1s spectra c), N1s spectra d). 
 The surface atomic compositions before and after functionalization of Nylon 6 
investigated by XPS analyses are given in Table 4. The oxygen (O) decreased percentage 
[112], which occurred after Nylon 6-NH formation, indicates successful reduction that is also 
supported by FT-IR spectra in Figure 26. The presence of chlorine on Nylon 6-NH surface 
confirms ammonium salt formation as a result of washing with 1 M HCl. The chlorine (Cl) 
percentage decrease after N-alkylation and grafting reactions can be considered as a signal 
for the reaction on the Nylon 6-NH surface with secondary amine groups. The achievement 
of N-alkylation on Nylon 6-NH samples leading to the Nylon 6-NCH2Ph formation has been 
reinforced by Raman spectroscopy (Figure 29). The conversion of Nylon 6-NH to Nylon 6-N-
PEG-CH3 (2 h lithiation, 0.6 ml t-BuLi) was indicated by the decrease percentage of chlorine 
on the surface after grafting that explains the N-alkylation reaction with H3C-PEG-OTs on the 
sites of ammonium ion on the nylon 6-NH surface. Nylon 6-N-PEG-CH3 (24 h lithiation, 2 ml 
t-BuLi) indicated more intensity of grafting as chlorine was completely absent in the 
composition of material. Moreover, the oxygen (O) percentage was increased after grafting 
due to immobilization of PEG-CH3 chains. This was further employed by Nylon 6-N-PEG-
CH3 samples̛ FT-IR spectra Figure 26. 
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Table 4: XPS data for the modified and unmodified Nylon 6 films 
 
Sample 
Elemental composition (%) of sample surface 
C N O Cl 
Nylon 6 75.89 11.05 13.06 -- 
Nylon 6-NH 78.91 10.31 6.27 4.51 
Nylon 6-NCH2Ph (3 h) 83.62 7.46  8.83 -- 
Nylon 6-N-PEG-CH3 
(2 h lithiation, 0.6 ml t-
BuLi) 
Nylon 6-N-PEG-CH3 



















4.2.2.5. FT-IR and Raman analyses  
 Figure 26 shows the comparison between the FT-IR spectra of Nylon 6 and modified 
Nylon 6-NH films. The characteristic stretching vibrations were seen for amide I and amide II 
groups (1660 cm-1 and 1541 cm-1), the aliphatic groups (2858 cm-1 and 2931 cm-1) and the 
secondary amine groups (3293 cm-1) present on Nylon 6 were visible for both samples 
before and after the reduction with BH3-THF. This was because of the FT-IR penetration 
depth, which was approximately 1 µm and formed layer was significantly thinner than 1 µm 
[111]. There was a new band appearing at 2420-2250 cm-1 and spectra band (2382 cm-1) 
which corresponded to imine groups introduced via chemical treatment, indicating the step 
towards reduction of amide to amine. Moreover, the increase in intensity of aliphatic band 
stretching vibration confirmed the amide conversion into amine due to the Nylon 6 film 
reduction. The FT-IR spectra of the Nylon 6-N-PEG-CH3 (2 h/ 0.6 ml t-BuLi), Nylon 6-N-
PEG-CH3 (2 h/ 1 ml t-BuLi)  and Nylon 6-N-PEG-CH3 (2 h/ 2 ml t-BuLi) samples showed that 
the imine stretching band (2420 - 2250 cm-1) disappeared completely. This fact was 
significant and indicated the Nylon 6-NH surface modification which occurred via lithiation. 
The characteristic PEG stretching band (1087 cm-1) was also very prominent for all the 
grafted samples. Again the stretching vibration intensities at 1087 cm-1 for the grafted 
samples were proportional to the t-BuLi concentration during lithiation. The WCA 
measurement (Figure 19), SEM analysis (Figure 21 e, f, g), AFM analysis (Figure 23, 24) 




 Figure 27 shows the spectra for Nylon 6-N-PEG-CH3-Cu, where some additional 
peaks appeared at 1726 cm-1, 1250 cm-1 and 952 cm-1. The absorption bands at 1726 cm-1, 
1250 cm-1 and 952 cm-1 attributed to the aliphatic ketone, asymmetric stretching vibration of 
S=O of sulfate (head group) in SDS molecules and C-O-S bond in SDS respectively. These 
additional stretching vibrations compared to Nylon 6-N-PEG-CH3 spectra confirmed the 
adsorption of SDS capped Cu NPs [146,160]. The characteristic PEG stretching band (1087 
cm-1) on Nylon 6-N-PEG-CH3 was red shifted to 1078 cm
-1 as a result of the presence of 
SDS capped Cu NP on Nylon 6-N-PEG-CH3 surface.  
 Figure 28 compares the FT-IR spectra of Nylon 6-NH and Nylon 6-N-PEG. The 
characteristic stretching vibration at 1078 cm-1 was attributed to PEG chains tethered by 
conjugation with DSC [158]. The additional peaks appeared at 1207 cm-1 and 1726 cm-1 
represented the ester bond formation during conjugation of PEG with DSC and aliphatic 
ketone on the surface. Nylon 6-N-PEG sample also showed that the imine stretching band 
present in Nylon 6-NH (2420 - 2250 cm-1) disappeared completely. Therefore, it was an 
indication for successful immobilization of PEG via DSC conjugation. 
 




Figure 27: FT-IR spectra showing Cu NP deposited Nylon 6-N-PEG-CH3 sample. 
 
Figure 28: The FTIR spectra comparing Nylon 6-NH and Nylon 6-N-PEG. 
 Nylon 6-NCH2Ph films could not be detected by FT-IR due to the sensitivity limitation 
[161]. Therefore, the surface composition changes were studied by Raman spectroscopy. 
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The strong Raman shift (Figure 29) for C-H stretching vibrations of aromatic ring was visible 
at 3060 cm-1 (i.e. within the range of 2870-3100 cm-1) for Nylon 6-NCH2Ph films, obtained by 
both 1 and 3 h reactions. Although the Raman intensity was higher in case of 3 h reaction 
confirming better modification in longer time. The Nylon 6-NH Raman spectra did not show 
any stretching band at 3060 cm-1. Moreover new strong stretching vibration bands were 
seen for Nylon 6-NCH2Ph films at 1625 cm
-1 and 1000 cm-1 due to the presence of C=C 
bonds coming from aromatic ring respectively. Raman spectra showed the characteristic 
stretching bands at 2900 cm-1 (aliphatic C-H), 1637 cm-1 (amide I groups) and 1439 cm-1 
(aliphatic CH2) for Nylon 6-NH as well as Nylon 6-NCH2Ph films. 
 
Figure 29:  Raman spectra confirming the modification Nylon 6-NH into Nylon 6-NCH2Ph. 
4.2.3. Analyses of antibacterial activity, cytotoxicity and cell adhesion 
4.2.3.1. Antibacterial activity of the prepared Nylon 6 samples 
Generally accepted principles concerning hydrophobicity in many cases describe 
how bacterial adhesion directly correlates with the surface [162]. Bacterial adhesion in 
response to the surface charge is a complex topic involving incubation time and surrounding 
ionic strength. When we look for the surface topography influence, which is usually 
described only by the average roughness parameter, it was rarely studied [163]. The exact 
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correlation between topography and bacterial adhesion is still unclear, although it is 
generally accepted that bacteriologically similar topographical properties support the 
adhesion of bacteria, presumably by providing protective effects. 
The tested samples were sample 1 – 9, unmodified Nylon 6 and other modified Nylon 
6 films mentioned earlier (Section 3.2.3.2 and 3.2.3.3). All the samples were cut into 
squares (2 cm x 2 cm size). Obtained results are summarized in Table 5 for S. aureus and in 
Table 6 for P. aeruginosa.  
 Results obtained with Gram positive bacteria S. aureus showed visible differences 
among the unmodified sample 1 and modified samples 2 - 9 (Table 5), but as it was 
described previously, pure Nylon 6 films generally exhibit lower adhesion for Gram positive 
S. aureus [164]. All examined grafted samples (3 – 8) seemed to have the significant 
antibacterial activity compared to the control and pure Nylon 6 (Sample 1). The PEG-CH3 
grafted samples 3, 4 and 6 particularly had high antibacterial activities. Surprisingly, Nylon 6-
NH (Sample 2) exhibited significant antibacterial efficacy for both the bacterial strains. 
Sample 2 showed > 99% inhibition for both S. aureus and P. aeruginosa. Additionally, Gram 
negative bacteria P. aeruginosa showed more interesting results, where significant 
differences were seen among the unmodified and modified samples (Table 6). Samples 3, 4 
and 7 displayed the highest antibacterial activity against P. aeruginosa amongst PEG-CH3 
grafted samples that were tested. According to the studies done by Jeon and co-workers, 
protein resistance to PEG-functionalized surface in water depends on the Van der Waals 
attractions and steric repulsion between solid substrate and protein [165]. Water molecules 
of hydrated PEG also play an important role. PEG chains result a low Van der Waals 
interactions with protein. If protein approaches to surface, the PEG chains are compressed 
and the steric repulsion becomes greater than attraction. The same mechanism may be 
applied as the reason for resistance to the bacterial adhesion. The grafting intensity was less 
in sample 3 compared to other grafted samples. Samples 3 and 4 had more access to the 
hydrogen bonding with water molecules due to the abundant exposure of –CH2-CH2-O– 
units, making samples 3 and 4 more hydrophilic than others, even though all the samples 
have hydrophobic terminal –CH3 groups. Samples 5 - 8, as more densely packed with H3C-
PEG chains, may not be able to form hydrogen bonds as efficiently as samples 3 and 4 with 
water. Moreover, the terminal –CH3 groups of H3C-PEG chains can make the densely 
drafted layer less hydrophilic, thus reducing the antibacterial efficacy. Comparing both the 
bacterial strains, it was clear that P. aeruginosa is comparatively less effective for grafted 
samples as relatively hydrophobic microbes (like P. aeruginosa) interact more strongly with 
PEG grafted materials [44].  
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 In case of Sample 9 (Nylon 6-N-PEG-CH3-Cu), Metallic Cu NPs of average size ~ 
500 nm were deposited by physisorption on Nylon 6-N-PEG-CH3 sample. Recently, Cu NPs 
have gained potential as effective and cheaper alternative antibacterial agent, especially 
after the extensive use of silver (Ag) nanoparticles in biomedical field [127,166]. The 
antibacterial efficacy of Cu NPs is dependent on the size of the particles and high surface to 
volume ratio, that allow the microbial membranes to interact effectively [166]. Sample 9 
snowed 99% bacterial inhibition against P. aeruginosa, whereas, it was not equally effective 
for S. aureus inhibition (Table 5, 6). Nylon 6-NH (sample 2) and the grafted samples showed 
higher inhibition for S. aureus. On the contrary, sample 9 exhibited strong antibacterial effect 
for P. aeruginosa compared to the all grafted samples.   
Table 5: Antibacterial activity of the unmodified (S1) and modified (S2 – S8) Nylon 6 samples against 
S. aureus 








Bacterial inoculum (S. aureus) concentration 
(100 = 3 x 107 CFU/ ml) 
100 10-1 10-2 10-3 10-4 10-5 10-6 10-7 
Control * * * * 975 107 11 1 
S1 * * * 603 284 26 5 0 
S2 18 2 1 1 0 0 0 0 
S3 166 31 10 4 0 1 0 0 
S4 562 138 43 7 1 1 0 0 
S5 * * 895 280 33 1 1 0 
S6 326 50 3 0 1 0 0 0 
S7 * * * 763 176 18 2 0 
S8 * * 736 134 7 1 0 0 
S9 * * * 957 91 22 4 0 
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Table 6: Antibacterial activity of the unmodified (S1) and modified (S2 – S8) Nylon 6 samples against 
P. aeruginosa 
(*) implies uncountable number of bacterial colonies. 
Qualitative antibacterial tests of Nylon 6-N-PEG-CH3-Cu 
 The zone of Inhibition Test results are shown in Figures 30 and 31 that exhibited 
significant antibacterial effect for both the bacterial strains.  The Cu NPs deposited samples 
(Nylon 6-N-PEG-CH3-Cu - sample 9) examined by the size of the inhibition zones (Table 7) 
presented stronger sterilization to P. aeruginosa compared to S. aureus. From both the 
figures, it can be seen that both the petri dishes were densely populated by both the 
bacterial colonies, exempting the areas of the samples placed on the agar. Moreover, the 
experiments showed 1mm zone of inhibition to P. aeruginosa around the functional 
specimen (Figure 31). In case of S. aureus, the inhibition zone was seen only below the 
sample. A few individual tiny bacterial colonies were also spotted on the sample surface 
(Figure 30). According to some literatures, Gram positive bacteria (S. aureus) are more 
sensitive to the Cu NPs than Gram negative ones (P. aeruginosa) [59,166,167]. But the 
degrees of toxic effect of Cu NPs are related to the nanoparticle size, where smaller 
nanoparticles (less than 100 nm diameter) are much more effective in bacterial sterilization 




Bacterial inoculum (P. aeruginosa) concentration 
(100 = 3 x 107 CFU/ ml) 
100 10-1 10-2 10-3 10-4 10-5 10-6 10-7 
Control * * * * 1102 93 15 3 
S1 * * * * 892  131 18 1 
S2 923 272 14 4 1 1 0 0 
S3 * 456 36 12 2 2 1 0 
S4 * * 452 70 6 2 0 0 
S5 * * * 879 376 65 6 0 
S6 * * * 516 104 6 0 0 
S7 * * 464 30 3 0 0 0 
S8 * * * 604 128 83 3 0 
S9 684 88 11 1 0 0 0 0 
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activity, penetration and impact on the cell may be increased [167].  In our experiments, both 
the qualitative and quantitative antibacterial tests proved to be more effective to P. 
aeruginosa than S. aureus for Cu NPs (~500 nm) deposited samples. 
 
Figure 30: Pictures of the visual control of inhibiting zones of S. aureus, exposed to Nylon 6-N-PEG-
CH3-Cu a) and after removal of Nylon 6-N-PEG-CH3-Cu b). 
 
Figure 31: Pictures of the visual control of inhibiting zones of P. aeruginosa, exposed to Nylon 6-N-
PEG-CH3-Cu a) and after removal of Nylon 6-N-PEG-CH3-Cu b). 
Table 7: Zone of inhibition measurement of Nylon 6-N-PEG-CH3-Cu against two bacterial strains: S. 
aureus and P. aeruginosa 
 Size of inhibition zone 
Sample size S. aureus P. aeruginosa 
20 mm × 20 mm 20 mm × 20 mm 
(Only below the sample)  
22 mm × 22 mm 
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4.2.3.2. Bacterial adhesion assessment 
 The bacterial adhesion resistance to the surface of the pure Nylon 6 (sample 1), 
Nylon 6-NH (sample 2), the previously mentioned grafted Nylon 6-N-mPEG films (samples 3 
-8) and Nylon 6-N-PEG-CH3-Cu (sample 9) against two bacterial strains: S. aureus and P. 
aeruginosa, was evaluated by counting the number of bacterial colonies formed in agar 
media incubated for 48 h/ 37° C. The results are summarized in Table 8 and Table 9 
respectively. All the grafted Nylon 6-N-PEG-CH3 samples (samples 3 – 8) exhibited 
significant resistance towards both S. aureus and P. aeruginosa adhesion compared to 
unmodified Nylon 6 (sample 1). Nylon 6-NH (sample 2) demonstrated high efficiency to 
resist both the bacterial adhesion, which corresponds to the antibacterial tests (Table 5, 6). 
The performance of samples 3, 4 and 6 were better than the other grafted samples. Pure 
Nylon 6 was very prone to bacterial adhesion as it showed high number of bacterial colony 
formation similar to the control. Sample 9 was very effective to P. aeruginosa with 99% 
efficacy, but did not high efficiency to resist S. aureus adhesion. 
Table 8: Bacterial adhesion analyses on the unmodified (S1) and modified (S2 – S8) Nylon 6 




Bacterial inoculum (S. aureus) concentration 
(100 = 3 x 107 CFU/ ml in control) 
100 10-1 10-2 10-3 10-4 10-5 10-6 10-7 
Control * * * * 975 107 11 1 
S1 * * * 904  100 9 1 0 
S2 13 11 7 0 0 0 0 0 
S3 5 0 0 0 0 0 0 0 
S4 61 13 6 0 0 0 0 0 
S5 370 59 7 3 0 0 0 0 
S6 37 0 0 0 0 0 0 0 
S7 * 672 78 8 0 0 0 0 
S8 295 36 3 0 0 0 0 0 
S9 * 368 73 6 0 0 0 0 
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(*) implies uncountable number of bacterial colonies. 
Table 9: Bacterial adhesion analyses on the unmodified (S1) and modified (S2 – S8) Nylon 6 
surfaces against P. aeruginosa 
(*) implies uncountable number of bacterial colonies. 
4.2.3.3. Cytocompatibility assessment of pure and modified Nylon 6 
Cytotoxicity of extracts  
 Metabolic activities of pure Nylon 6 foil (Sample 1) and all other modified foils 
(Samples 2 – 9), incubated in complete medium using 10 mg of tested material/ 1 ml of 
medium for 24 hours, were measured by MTT test. The results are summarized in graph in 
Figure 32 a. Samples 3 and 9 were found to be cytotoxic with cell viabilities 12% and 16% 
respectively for 10 mg tested material/ ml extract concentration. The rest of the samples 
(Samples 1, 2, 4 – 8) exhibited no cytotoxicity measure in cells as cell viability exceeded 
70% limit of cytotoxicity given by the ISO norm. However, samples 4 – 7 caused the drop of 
cell viability to 85%, 80%, 79% and 82% respectively, that are close to the determined level 
of cytotoxic effect given by the norm (70%). Samples 1, 2 and 8 showed high 




Bacterial inoculum (P. aeruginosa) concentration 
(100 = 3 x 107 CFU/ ml in control) 
100 10-1 10-2 10-3 10-4 10-5 10-6 10-7 
Control * * * * 1102 93 15 3 
S1 * * * 422 37 4 0 0 
S2 1 0 0 0 0 0 0 0 
S3 12 1 0 0 0 0 0 0 
S4 452 69 11 2 0 0 0 0 
S5 792 168 30 3 0 0 0 0 
S6 45 3 0 0 0 0 0 0 
S7 174 63 2 0 0 0 0 0 
S8 800 57 6 1 0 0 0 0 
S9 8 0 0 0 1 0 0 0 
86 
 
hand, all the tested materials with lower extract concentration of 5 mg/ ml demonstrated 
cytocomplatibility. Moreover, samples 3 and 9 led to slight reduction of cell viabilities to 83% 
and 90% respectively compared to control (Figure 32 b) . Lower absorbance of solution 
reflecting cell metabolic activity suggested potential cytotoxic effect orf the samples 3 and 9 
using 10 mg tested material/ ml extract concentration, whereas both the samples were found 
to be non-cytotoxic for 5 mg tested material/ ml extract concentration.  
 
 
Figure 32: Metabolic activities of fibroblasts (3T3-SA) after 24 hours incubation in complete medium 
(NC), complete medium containing Triton X-100 (PC) and extracts of the tested samples (Samples 1 - 
9) in concentrations of 10 mg/ ml a) and in complete medium (NC), complete medium containing 











































 Before performing metabolic MTT tests for the samples, cells were captured by 
optical microscopy. Cells cultured in the presence of complete medium (DMEM) had normal 
spread morphology (Figure 33 a). Dead rounded cells were found in wells containing DMEM 
with addition of cytotoxic Triton X-100 (Figure 33 b). Extracts of all the tested samples in 
lower tested concentration of 5 mg/ ml caused no visible cell damage. On the contrary, 
extracts of samples 3 and 9 in higher tested concentration (10 mg/ ml) caused visible cell 
damage (Figure 33 c – f). Only for these two samples, extracts in diluted concentration (5 







Figure 33: Optical microscopy pictures of 3T3 fibroblasts after 24 hours of incubation in DMEM a), 
DMEM + Triton X-100 b), sample 3 in concentrations of 10 mg/ ml c), Sample 3 in concentrations of 5 
mg/ ml d), sample 9 in concentrations of 10 mg/ ml e), sample 9 in concentrations of 5 mg/ ml f). 
Direct contact cytotoxicity  
 Direct contact cytotoxicity with the tested materials (samples 1 – 9) was evaluated by 
measurement of cell metabolic activity after 24 hours of incubation and the results are shown 
in Figure 34. The tested foils were floating in the media with subtle contact with the bottom 
where the cells were grown. Therefore, slightly limited metabolic activity in the wells 
containing material does not mean the cytotoxic effect of the material. The limited metabolic 
activity in the wells containing materials also may be observed due to the mechanical 
damage during foil removal after 24 hour incubation. Measured cell viability for samples 1, 2 
and 4 - 8 in contact with foils reached 80-90% of metabolic activity of cells cultured in 
complete medium. No significant reduction in cell metabolism has been observed for the 
mentioned samples, therefore materials could be considered as cytocompatible with 3T3 
mouse fibroblasts upon direct contact. Samples 3 and 9 were signified to be cytotoxic as the 
overall metabolic activity decreased up to 25% and 11% respectively of control cells. 
Moreover, their metabolic activity was also comparable to control cells. Similar results were 




Figure 34: Metabolic activity of fibroblasts after 24 hours incubation in complete medium (NC), in 
complete medium + Triton X-100 (PC), in complete medium with presence of samples 1 – 9. 
 Before MTT assay, the incubated cells were assessed microscopically. Control cells 
cultured in complete media created a confluent layer of spread fibroblasts after 24 h 
incubation (Figure 35 a). When cytotoxic Triton X-100 was present, floating dead cells were 
seen (Figure 35 b). Cells in wells with samples 1, 2 and 4 - 8 were viable with normal 
morphology. Well plates containing these tested materials were covered with cells. In case 
of samples 3 and 9, mostly dead cells were found in the wells containing samples. But 
farther away from these two samples, mixtures of dead and alive cells were observed. The 























Figure 35: Optical microscopy images of 3T3 fibroblasts grown in presence of DMEM a), DMEM + 
Triton X-100 b), cells in the bottom of well plate containing sample 3 c) and cells in the bottom of well 
plate containing sample 9 d). 
4.2.3.4. Cell adhesion  
 Staining of adhered cells by phalloidin - FITC in green and DAPI in blue on tested 
foils (Samples 1 – 8) was used to visualize cell spreading and adhesion after seeding the 
cells on the top of the materials. Fluorescence microscopy pictures after incubated for 1 day 
and 7 days are depicted in Figure 36. After 1 day, the highest cell adhesion rate was 
observed within materials 1 and 8. Cells were more spread than on the other samples 
(samples 2 – 7). Sample 1 (pure Nylon 6) was covered by monolayer of the fibroblast cells. 
However, the foil was not covered by 100%. There were islets of monolayers and parts 
without any cells present. It suggested that longer time of incubation would be needed for 
100% confluency of the sample 1 surface. After a week of culturing, sample 1 exhibited 
acceptable adhesion rate followed by high proliferation rate of the cells and cell monolayer 
with normal cell morphology was observed on the foil surface. On the contrary, after 7 days, 
the cells on sample 8 had unusual morphology; cell nuclei were bigger than normal cells with 
a lot of fragments around. After 1 day of incubation, the rest of the samples (samples 2 – 7) 
did not support cell adhesion as cellular spreading was very limited and only round cells with 
low amount of cytoplasm was found. After a week of incubation, cell numbers were also 
decreased further. This observation proposed that most of the samples did not allow further 
adhesion and proliferation of the cells during a week of culturing. The Nylon 6-NH (sample 2) 
and other grafter foils did not support fibroblast proliferation although no cytotoxicity of the 
samples were detected except sample 3. On the samples 5 and 7, occasional monolayer of 
cells were observed in forms of separated islands. Cell adhesion of fibroblasts to all tested 
surfaces (samples 1 – 8) after 1 day incubation is depicted in the first column of the Figure 
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36 (a1 – h1). The second column in Figure 36 (a2 – h2) represents cell adhesion after 7 days 









Figure 36: Fluorescence microscopy pictures of foils seeded with fibroblasts after 1 day of culturing 
for samples 1 – 8 a1 – h1) and after 7 days of culturing for samples 1 – 8 a2 – h2) [objective 20X]. 
 Cell spreading on pure and functionalized Nylon 6 foil surfaces was assessed by 
scanning electron microscope (SEM). The results are in agreement with outcomes from 
fluorescence microscopy described above. 1 day after seeding, cells adhered on the 
surfaces of foils. Differences in cellular spreading were observed after 7 days. Rounded 
small cells indicated low adhesion while fully spread cell with creation of fillopodia signifies 
strong adhesion of cells to the surface. SEM also enabled the visualization on surface of 
tested materials. Mostly, smooth foils were captured except for sample 5. Increased surface 
roughness could have influenced cell material interactions. In samples 5, 7 and 8, occasional 
monolayers were formed (such as observed by fluorescence microscopy). Reduced number 
of cells after 7 days of incubation was found on samples 2, 3, 4 and 6. Sample 1 showed 
high proliferation on the sample surface. Figure 37 (a – h) represents the SEM pictures 





Figure 37: SEM images of fibroblasts captured on tested foils after 7 days of incubation for samples 1 
– 8 a – h). 
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 The PEG based antifouling coatings have been widely reported in various literatures 
[168–170].  PEG immobilization is the most commonly used approach to impart protein 
resistance to the surface. Therefore, it was expected that the cell adhesion would be 
affected on grafted samples of Nylon 6 (samples 3 – 8). Surprisingly, Nylon 6-NH did not 
allow the fibroblast cell to adhere on the surface although it demonstrated cytocompatibility. 
Pure Nylon 6 surface provided suitable condition for cell adhesion and proliferation. 
 Functional metabolic assay (colorimetric MTT assay after 1 and 7 days cell seeding) 
was used in order to quantify cell viability on tested materials. Results are summarized in 
Figure 38 (a, b). After 1 day, low metabolic activity was measured in all tested samples 
including the control (tissue culture plastic - TCP). During 7 days of experiments, metabolic 
activity of cultured cells was increased in TCP and sample 1. On the contrary, cell metabolic 
activity decreased after 7 days of incubation for the Nylon 6-NH (samples 2) and all the 
grafted samples (samples 3 – 8). This observation implies that these samples were with a 
very limited metabolic activity. The outcome confirms assumption of low adhesion of cells to 
Nylon 6 modified samples. Materials were found to be non-adherent for cells that could be 
























Figure 38: Metabolic MTT test of control (TCP) and tested samples (1 - 8) seeded with fibroblasts 
after 1 day a) and 7 days b). 
 Antibacterial tests for modified Nylon 6-NH and PEG-CH3 chain grafted Nylon 6 
samples against both Gram positive (S. aureus) and Gram negative (P. aeruginosa) 
pathogenic bacterial strains exhibited significant effectiveness on the bacterial adhesion 
compared to pure Nylon 6 sample. Water contact angle values played important role on 
bacterial adhesion resistance. The increased hydrophilicity imparted positive influence on 
the bacterial adhesion resistance and antibacterial effect of modified Nylon 6-NH and grafted 
samples compared to Nylon 6. Pure and most of the modified Nylon 6 samples (except 
samples 3 and 9), did not exhibit cytotoxicity for the fibroblast cells on direct contact; 
whereas, all the samples proved to be non-cytotoxic for the fibroblast cells under sample 
extract with the concentration of 5 mg/ ml. On the other hand, the cell adhesion was 


















After 7 days cultivation b 
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4.3. Copper Nanoparticles (Cu NPs) 
4.3.1. Synthesis of copper nanoparticles  
 The synthesis of Cu NPs by reduction is one of the common “bottom up” methods.  
This wet chemical technique has its own advantages and disadvantages, like other methods. 
The equation for the reduction of Cu+2 to the zero-valent Cu NPs is given below [146]: 
 
Here sodium borohydride (NaBH4) was used as reducing agent along with sodium dodecyl 
sulphate (SDS) as capping agent to prevent the oxidation of Cu NPs in aqueous medium 
and the aggregation for ensuring the control on particle growth. The mechanism was seed-
mediated growth via external reducing agent (NaBH4) that induced nanoparticle formation in 
presence of SDS as surface stabilizer (scheme 6). The aqueous medium was densely 
populated with SDS surfactant micelles, as the concentration is above the critical micelle 
concentration (CMC) [146]. The Cu+2 ions in the solution accumulated at the negatively 
charged micelle head groups due to electrostatic attraction. During the addition of NaBH4 
(reducing agent), the electron transfer occurred from borohydride anions (BH4¯) to copper 
cations (Cu+2) and that led to the nucleation of copper atoms. The nascent nuclei tended to 
connect each other to make nanoparticles of definite shape and within a range of size [171]. 
 Metal NPs including Cu NPs have been synthesized in variety of shapes including 
cube, cuboctahedron, octahedron, tetrahedron, decahedron, thin plate, and rod. NP shape is 
controlled by the thermodynamics and growth kinetics of the dynamic system composed of 
the inorganic core, the ligands (surfactant molecules), and the solution that contains 
chemical precursors and ligand species [172]. Here the shape of Cu NPs synthesised were 
cubical. Very recent studies have investigated the cube-shaped NP formation [173,174]. The 
Wulff construction has been used to predict the equilibrium shape of NPs, when Gibbs 
proposed that the equilibrium shape of a droplet of matter is determined by a surface energy 
minimization [173]. Intuitively, spherical or roughly spherical polyhedral shapes with the 
lowest surface-to-volume ratio (i.e. number of surface atoms over number of bulk atoms) are 
the most likely to form from NP seeds, although NPs with various shapes are obtained. For 
chemical synthesis, a shape-formation mechanism has been proposed, concerning the 
ability of surfactant ligands to move selectively on the NP surface, which allows specific 
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facets to grow instead of others as ligand adhesion decreases the energy. Thus, different 
growth rates result the specific NP shapes [174]. Temperature and ligand concentration are 
key parameters in this context. Liao et al. showed the sequential images for the growth of 
the platinum (Pt) nano-cube using high-resolution TEM (transmission electron microscopy) 
to explain the formation of cubic NPs from spherical seeds [173].  In our case, the same 
explanation may be applicable. 
 
Scheme 6: Mechanism for the formation of Cu NPs in aqueous SDS solution. 
4.3.2. Characterization  
 The DLS measurements were performed to determine the particle size and to 
evaluate the influence of the reaction time on the particle size. The sizes of the prepared Cu 
NPs at different time after reaction showed in Figure 39. In the graph, the intensity (%) was 
plotted against the various sizes of Cu NPs (nm). In DLS technique, the particles of different 
sizes scatter with different intensities in dependence of the scattering angles, therefore there 
are optimum angles of detection for different particle sizes. After 1 h of reaction the particle 
size was comparatively less with mean 342 nm, but after 24 h the particle size increased to 
range of 220 - 825 nm with the mean particle size 459 nm. During 1 h reaction, the colour of 
the aqueous solution was deep brown, whereas after 24 h the solution turned to 
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characteristic brick red colour that indicated the stability of Cu NPs in the solution in 
presence of SDS [175]. Moreover, the Cu NPs aggregated after 15 days forming larger 
particles with mean particle size 712 nm. 
Table 10: The size of Cu NPs at different times after reduction  
Time Particle size range, nm Average particle size, nm 
1 h 51 - 825 342  
24 h 220 - 825 459  
15 days 460-955 712 
 
 
Figure 39: The Copper nanoparticle size distribution by intensity (%) at different time after reaction. 
 Figure 40 a shows the SEM micrograph of SDS capped Cu nanoparticles prepared 
by reduction of Cu+2 to the zero-valent Cu in aqueous solution. Large Cu NPs were formed 
after 24 h of reaction by the agglomeration in Cu seed particles, which are nearly spherical in 
morphology [176]. The seed particles grew exclusively to cubic ones. The particle sizes 
varied widely although the Cu NPs’ morphology was uniformly cube-shaped for all particles. 
The histogram of particle size distribution (Figure 40 b) revealed that the seed particles of 
Cu agglomerated to form different batches of Cu NPs having different sizes in the wide 
range of 100 – 1100 nm (Mean = 466 ± 214 nm). This result is nearly corresponding with the 
particle size values by DLS, where after 24 h the mean particle size was detected as 459 
nm. The histogram showed that almost 80% of all the measured particles were falling under 

























Figure 40: SEM image of SDS stabilized Cu NPs a) and a histogram of particle size distribution b). 
 Figure 41 shows the UV-VIS absorption spectra of the Cu NPs. No surface plasmon 
resonance (SPR) peak was observed after 15 mins reaction. The SPR peak appeared at 
570 nm after 1 h of reaction. These results are in good agreement with the reported values 
of 550 to 590 nm [171]. This confirmed the formation of Cu NPs by the adopted procedure.  
 
Figure 41: UV-VIS absorption spectra of Cu NPs in aqueous medium, prepared by reduction reaction. 
 The FT-IR spectra of SDS and SDS stabilized Cu NPs were studied to examine 
surface binding interactions (Figure 42). The characteristic stretching vibrations of SDS 
were identified at 3460 cm-1 (H-bonding due to absorption of moisture), 1471 cm-1 and 1383 
cm-1 (-CH3 asymmetric and symmetric stretching vibrations). Two absorption bands at 2923 































aliphatic tail group (-CH2-) in SDS. The spectra bands at 1225 cm
-1 and 996 cm-1 
corresponded to sulphate head group (S=O) and C-O-S bond in SDS molecule [160]. 
Moreover, 1225 cm-1 band of pure SDS was blue-shifted to 1252 cm-1 due to the presence of 
Cu NPs. It confirmed the Cu NP stabilization due to the negatively charged head groups 
SDS [146]. The SDS capped Cu NPs exhibited red shifting of 996 cm-1 band to 952 cm-1. 
 
Figure 42: FT-IR spectra of SDS and SDS capped Cu NPs. 
4.3.3. Application  
 The Cu NPs are used in various purposes including as antibacterial agent as we 
discussed earlier. Here, the prepared Cu NPs were used in the experiment for the deposition 
of Cu NPs on grafted Nylon 6 (Nylon 6-N-PEG-CH3) surface (Section 3.2.1.8.) after 
characterization. In this specific work, the Cu NP deposited samples were examined for the 
efficacy of antibacterial activities for both Gram positive (S. aureus) and Gram negative 
bacteria (P. aeruginosa) (Section 4.2.3.). The Cu NPs collected after 24 h of reaction were 
used for the all the antibacterial tests and cytotoxicity assessments. 
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4.4. Mesoporous Silica Nanoparticles (MSNs) 
4.4.1. Synthesis of mesoporous silica (SiO2) nanoparticles (MSNs) 
 The schematic overview of the synthetic approach to mesoporous silica materials are 
shown in scheme 7. The synthesis of templated mesoporous silica follows as few steps: 
dissolution of template molecules (CTAB or P123) in the solvent (usually water), addition of 
the silica source (TEOS or fumed silica), stirring at required conditions to allow the hydrolysis 
and pre-condensation, recovery of the product and the final stage of template removal by 
calcination [135]. Hydrolysis may occur both in acidic or basic medium. The equations for 
hydrolysis and condensation of silicates are given below [177]: 
Hydrolysis: OH¯ + Si(OR)4 → Si(OR)3OH + RO
¯      (1) 
Condensation: SiO¯ + Si(OH)4 → Si–O–Si + OH
¯      (2) 
 
Scheme 7: Overview of synthetic approach to the mesoporous silica formation. 
 Soft templating, including micelle templating, offers an alternative facile and 
environmental friendly approach for MSNs preparation. The structure transformation of 
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amphiphilic surfactant organizations can be understood by the surfactant packing factor/ 
parameter, g = V/ l.a0, where V is the volume of the hydrophobic chains in surfactant, l is the 
surfactant chain length, and a0 is the effective area of the hydrophilic head group of the 
surfactant at the interface [136]. Generally, surfactants with lower critical micelle 
concentration (CMC) are more favoured to obtain ordered structure. According to the 
classical micelle chemistry, above a critical value, g-packing factor increases and therefore, 
mesophase transitions occur. When g < 1/ 3, particles tend to form Pm3n cubic structure 
and mixed 3-D hexagonal structure and cubic structure; when 1/ 3 < g <1/ 2, particles tend to 
form p6mm hexagonal structure; when 1/ 2 < 2/ 3, particle tend to form Ia3d cubic structure; 
when g ~ 1, lamellar structures are favoured [135,136]. Figure 43 depicts the schematic 
representation of surfactant behaviour in the aqueous medium as a function of g-packing 
factor.  
 
Figure 43: Surfactant behaviour in the aqueous medium as a function of g-packing factor. 
 The synthesis methods that were applied to produce the specific MSNs in this work 
are very well verified by various other researches many times [135]. It has been well 
established that by following these verified procedures the desired MSNs can be formed with 
distinct properties. Thus, the procedure used for MSNs are extremely reliable in terms of 
synthesis as well as characterization.  
4.4.2. Characterization  
 The SEM micrographs in Figure 44 (a – g) revealed that the obtained samples have 
different morphologies having various shapes and sizes. The particle sizes and shapes of 
different MSNs are summarized in Table 11. MCM-41 (FS) had agglomerated to form larger 
particles (> 1 µm), whereas MCM-41 (S) and MCM-41 (HO) showed highly ordered spherical 
and conical disc shaped nano-sized particles with polydispersity of particle size (Figures 44 
a – c) [135,147,178]. The particle sizes of MCM-41 (S) were seen in the range of 200 – 900 
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nm. On the other hand, MCM-41 (HO) exhibited more uniform nanoparticles with sizes 
between 400 – 600 nm. Figures 44 d, f and h (MCM-48, PHTS and FCF respectively) 
exhibited the agglomeration of the MSNs into clusters (> 1 µm) where the smaller particles 
are also clearly visible. SBA-15 (Figure 44 e) revealed comparatively uniform particles in 
terms of shape (bagel-shaped) and size (300 – 500 nm) [179]. The structures of mesopores 
in the silica particles could not be evaluated by SEM. The nature of the porous structures 
was examined by BET analysis.  
 
 
Figure 44: SEM images of MSNs: MCM-41 (FS) a); MCM-41 (S) b); MCM-41 (HO) c); MCM-48 d); 





Table 11: The range of Particle size and geometry of the particles measured by SEM 
Sample Geometry Particle size (nm) 
MCM-41(FS) agglomerated >1000 
MCM-41(S) Spheres 200 - 900 
MCM-41(HO) Cone discs 400 - 600 
MCM-48 agglomerated >1000 
SBA-15 Bagel-shaped (Short rods) 300 - 500 
PHTS agglomerated >1000 
MCF agglomerated >1000 
  
 Figure 45 shows N2 adsorption and desorption isotherms of the three different MCM-
41 samples prepared, which can be classified as type IV isotherms according to the IUPAC 
classification and that is typical to the mesoporous silica materials [180]. MCM-41 (FS) 
showed hysteresis loop typical of parallel cylindrical pores [181]. MCM-41 (S) and MCM-41 
(HO) exhibited similar N2 sorption isotherms where an increase in adsorption took place 
above P/ P0 = 0.2, suggesting the capillary condensation of N2 within the pores and 




Figure 45: N2-sorption isotherms at -196° C for MCM-41 (FS), MCM-41 (S) and MCM-41 (HO).   
 Figure 46 shows the N2 sorption isotherms of rest of the other four MSNs: MCM-48, 
SBA-15, PHTS and MCF. All the samples exhibited type IV isotherms as MCM-41. MCM-48 
demonstrated adsorption isotherm at higher relative pressure (P/ P0 > 0.9) that corresponds 
to N2 condensation in the interparticle voids and also reflects the small size of mesoporous 
[182]. SBA-15 exhibited H1 hysteresis loop starting from P/ P0 = 0.6, that is characteristic of 
SBA-15 with highly ordered pores [179]. The adsorption-desorption behaviour of PHTS was 
consistent with a structure comprising both open and blocked cylindrical mesopores [183]. 
PHTS showed two-step desorption where the first desorption step was similar to that of 
SBA-15, indicating the open mesopores. The second desorption step of PHTS was 
attributed to the plugs (NPs) within the mesoporous (Figure 47). For the plugged pores, 
desorption was delayed resulting in second desorption [135]. The hysteresis loop was 
appeared at P/ P0 = 0.4 – 0.75. MCF The MCF N2 sorption isotherm with characteristic long 




Figure 46: N2-sorption isotherms at -196° C for MCM-48, SBA-15, PHTS and MCF. 
 Figure 47 depicts the difference between usual mesoporous material (e.g. SBA-15) 
and PHTS with plugged pores. PHTS mesopores are narrowed by nanoparticles (plugs) to 
create inkbottle-like sections. On the contrary, SBA-15 has open mesopores [135]. Usually, 
small micropores are also exhibited on the walls of MSNs. 
 
Figure 47: Schematic representation of the pore structure: SBA-15 and PHTS. 
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 The characteristics of calcined mesoporous silica materials were analysed by BET 
for examining specific surface areas and the pore size distributions were determined by BJH 
model that were further verified by new DFT model. All the results are summarised in Table 
12. The previously widely used BJH model is no longer recommended for such applications 
in micro-mesoporous materials examination as it can significantly underestimate the pore 
size for narrow mesopores (for pore diameter smaller than 10 nm the pore size may be 
underestimated even by 30 %) [185]. However, BJH modelling was used to compare the 
synthesised materials with the specifications found in the literature [135]. The results were 
good agreements with the previously mentioned published literature. All the MCM-41 
samples exhibited high specific surface area lying between 700 – 1120 m2/ g. The pore 
diameters are in the range of ~2 – 4 nm, although their morphologies were different. MCM-
48 showed relatively low surface area (470 m2/ g) compared to other MSNs, although the 
pore diameter is similar to the MCM-41 (S) sample. The specific surface area of SBA-15 was 
high (1020 m2/ g) with larger pore diameter (~8 nm) compared to MCM series. PHTS also 
displayed high surface area with 940 m2/ g and the pore diameter of open pores were in 
between 5 – 7.5 nm, whereas the plugged pores were less than 2 nm. In this case, the DFT 
was considered as more reliable than BJH as there was a significant difference in 
adsorption/ desorption pore diameter for plugged pores. MCF displayed highest pore size of 
15 – 10 nm with 760 m2/ g surface area. MCM-41 (FS), SBA-15 and MCF exhibited 
comparatively higher pore volumes (2.34, 1.17 and 1.88 cm3/ g respectively). On the other 
hand, MCM-41 (S), MCM-41 (HO), MCM-48 and PHTS possessed the pore volumes ~0.7 – 
0.8 88 cm3/ g.   





















MCM-41(FS) 700 2.34 4.41 2.87 3.07 
MCM-41(S) 880 0.72 3.18 2.12 2.14 
MCM-41(HO) 1120 0.75 3.3 2.25 2.26 
MCM-48 470 0.77 3.18 2.12 2.22 
SBA-15 1020 1.17 7.59 8.97 6.33 
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PHTS 940 0.83 5.06, 1.64 7.12, 0.89 5.23, 3.87 
MCF 760 1.88 11.68 15.43 10.19 
 
 For all the synthesized MSNs, N2 sorption isotherms, BET and BJH (verified by DFT) 
data regarding pore sizes, surface areas and pore volumes were compatible with the verified 
once given in the literature [135]. Therefore, the pore structures (morphologies) are 
suggested to be the same as demonstrated in various literature mentioned earlier. Figure 48 
shows the transmission electron microscope (TEM) pictures of various MSNs prepared here. 
MCM-41(all 3 types) and SBA-15 formed hexagonal mesopores whereas, MCM-48 formed 
cubic structured mesopores. PHTS exhibited hexagonal large mesopores with micropores 





Figure 48: TEM images of MSNs: MCM-41 (FS) a); MCM-41 (S) b); MCM-41 (HO) c); MCM-48 d); 
SBA-15 e); PHTS f) and MCF g) [135]. 
4.4.3. Application of mesoporous silica (MSNs) 
 The textural properties such as high surface area, large pore volume and the narrow 
particle size distribution are well suited for the application of nano-encapsulation for drug 
delivery. Moreover, different types of prepared mesoporous silica allowed us for precise 
comparison of their properties (high polydispersity in particle size, different porosity, particle 
morphology and pore structure) for L-DOPA drug release [186]. For the evaluation of L-
DOPA delivery profile, MSNs with same pore sizes but different morphologies (MCM-41, all 
3 types) and MSNs with various pore sizes (MCM-48, SBA-15, PHTS and MCF) were 
chosen to understand the effect of pore size along with particle morphology on drug loading 
and release profile.  
4.4.4. L-dopa loading and release 
 L-DOPA is an amino acid that is made and used as part of the normal human body 
as well as some animals and plants. It can cross the protective blood-brain barrier unlike 
dopamine. Therefore, L-DOPA is used to increase dopamine concentration for the common 
Parkinson disease treatment. This treatment was proven clinically by G. Cotzias et. al. [187]. 
MSNs were widely explored for drug delivery using various types of drugs, whereas L-DOPA 
was not given any importance to have MSNs as the potential carriers [148,186]. In our 
research, the potential of using MSNs for specifically L-DOPA drug loading and release has 
been studied and evaluated. The illustration of the whole process for drug loading and 
release is given in scheme 8. The calculations for loading and release of drugs using 




Scheme 8: The illustration for L-DOPA drug loading to and release from mesoporous silica. 
4.4.4.1. L-DOPA drug loading  
 L-DOPA drug loading was monitored by UV-VIS spectrophotometer and the 
calibration curve (Figure 49) was plotted to calculate the concentration change with respect 
to time using the absorbance spectra for evaluating the L-DOPA loading.  
 
Figure 49: The standard calibration curve of L-DOPA in water. 
















Concentration (mg/ ml) 
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 The loading profiles of L-DOPA for MCM-41 (FS), MCM-41 (S) and MCM-41 (HO) 
are presented in Figure 50 a. It was expected to observe the differences in drug loading 
amount as the mentioned MSNs had different surface morphologies although the pore sizes 
were similar. Figure 50 b shows the drug loading profiles for rest of the mesoporous silica 
samples (MCM-48, SBA-15, PHTS and MCF). The curves show the drug loading (in µg) per 
10 mg of previously prepared mesoporous silica materials. Maximum loading was allowed by 
SBA-15 (59 µg) amongst all the mesoporous silica materials. SBA-15 is widely used for drug 
delivery and the obtained comparative results also support SBA-15 as the best mesoporous 
silica material. MCM-41 (FS), MCM-41 (S), MCM-41 (HO) and MCM-48 showed narrow 
difference in loaded drug (49 µg, 51 µg, 53 µg and 49 µg respectively) as the pore diameters 
of all MCM series materials were found to be similar. Highly ordered MCM-41 (HO) exhibited 
more loading compared to other MCM series materials due to uniformity of porosity as well 
as surface morphology. The MCM-41 (S) had spherical morphology, but particle sizes were 
less uniform than MCM-41 (HO), therefore loading was less than MCM-41 (HO). Due to 
large pore sizes of MCF, the loading performance of it (56 µg) was very close to SBA-15 and 
PHTS demonstrated minimum loading (42 µg), probably due to the presence of plugged 
pores. The L-DOPA loading was observed to be fast (2 h). The loadings were not continued 
more than 24 h as L-DOPA aqueous solution is very sensitive to light and heat. Moreover, 
the solution turns black as a result of degradation in solvent [190]. The amounts (wt%) of L-






























Figure 50: The L-DOPA loading profiles for MCM-41 (FS), MCM-41 (S), MCM-41 (HO) a) and MCM-
48, SBA-15, PHTS, MCF b). 
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4.4.4.2. L-DOPA drug release 
 Like L-DOPA drug loading, L-DOPA drug release in PBS was also monitored by UV-
VIS spectrophotometer. The calibration curve (Figure 51) was plotted using the absorbance 
spectra to measure the released drug concentration directly with respect to time for L-DOPA 































Figure 51: The standard calibration curve of L-DOPA in PBS. 
 The absorbance spectra recorded during the release of L-DOPA drug in different 
time intervals were used in order to prepare a plot indicating the release profile. The release 
profiles are depicted in Figure 52 (a, b). The results established that the release is sustained 
rather than prolonged [148]. The release profiles of all tested materials were quite similar. 
SBA-15 with high surface area and pore volume (pore diameter ~7.6 nm) achieved highest 
release amount with ~85% in 1 h whereas, PHTS revealed the lowest release (~74%). In 
MCM series, MCM-41 (HO) showed more drug release capacity (~81%) than others and all 
the results were compatible with the drug loading profiles. Both MCM-41 (FS) and MCM-48 
released ~78% of loaded L-DOPA, but MCM-41 (S) released ~80%. MCF having 
comparatively large pores (~12 nm) achieved ~83% drug release.  
 















































Figure 52: The L-DOPA drug release profiles for MCM-41 (FS), MCM-41 (S), MCM-41 (HO) a) and 
MCM-48, SBA-15, PHTS, MCF b). 
 The comparative studies of drug loading and release revealed that surface 
morphologies, specific surface area, pore volumes and pore diameters played important role 
in drug loading and release profiles of different MSNs. Amongst all the tested mesoporous 
silica materials, SBA-15 was found to be the best for L-DOPA drug loading and release. The 
analyses of drug loading and release profiles revealed that MSNs can be used for effective 










































5. CONCLUSION AND FUTURE WORK 
5.1. Conclusion 
 First, a novel, easily achievable and efficient surface modification of PET via one-
step reaction was successfully developed and applied for antibacterial resistance towards 
both Gram positive (Staphylococcus aureus and methicillin-resistant Staphylococcus aureus 
known as MRSA) and Gram negative (Escherichia coli and Pseudomonas aeruginosa) 
bacterial strains, without cytotoxic effect according to the ISO norm. The Grignard reagents 
were capable to react with PET foil and fabric surfaces which were confirmed by different 
analysis techniques, such as WCAs, and FSEs measurements, FTIR spectroscopy, 
fluorescence labelling, SEM, AFM microscopies. Ester cleavage of PET by different Grignard 
reagents resulted to the immobilization of hydroxyl groups (–OH) along with alkyl groups with 
various length C chains that can tune the hydrophilicity/ hydrophobicity as well as the FSEs 
which play important role in bacterial adhesion. Both the modified biocompatible PET foils 
(PET–CH3 and PET–C12H25) were found to be fairly resistant towards tested bacterial 
adhesion, especially against the pathogenic bacterial strain MRSA whereas the cell viability 
of all the tested samples was found to be greater than 80%. We would like to emphasize that 
an efficient fight and easily applicable solutions against increase of antimicrobial resistance 
generate current key challenges of global importance in biomedical application.  
 Second, the both non-spectral (WCAs and FSEs) and spectroscopic methods as well 
as microscopic analyses (SEM, AFM, XPS, FT-IR and Raman) confirmed that the naturally 
abundant surface amide groups of Nylon 6 were successfully and efficiently reduced to 
amine groups which were further modified by N-alkylation, by tethering PEG via DSC 
conjugation and by grafting PEG-CH3 chains via lithiation. The N-alkylation model reaction 
performed on Nylon 6-NH confirmed the scope of tuning the Nylon 6 surface through grafting 
hydrophilic antifouling PEG-CH3 chains via lithiation reactions and thus opened up a new 
efficient way for producing cytocompatible surface which can potentially help to extend the 
spectrum of applications including biomedical field. Moreover, the BuLi concentration as well 
as the lithiation time significantly influenced further PEGylation. Antibacterial tests against 
both Gram positive (Staphylococcus aureus) and Gram negative (Pseudomonas aeruginosa) 
pathogenic bacterial strains confirmed significant effect on the bacterial adhesion. Water 
contact angle values demonstrated the increase in hydrophilicity of modified Nylon 6-NH and 
grafted samples compared to pure Nylon 6. The hydrophilicity increase employed positive 
influence on resistance to bacterial adhesion and antibacterial effect on modified samples 
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compared to Nylon 6. Nylon 6-NH and all other grafted samples except Sample 3, exhibited 
noncytotoxic effect (on direct contact and under extract) on fibroblast cells. On the contrary, 
the cell adhesion was adversely influenced by the Nylon 6 surface modification. The 
modified samples have significant potential to be used in biomedical fields where 
antibacterial effect as well as bacterial adhesion resistance would be major priority than cell 
adhesion (e.g. artificial valves, catheters etc.).   
 Third, Cu NPs were prepared by Cu2+ reduction using NaBH4 and characterized by 
different analysis techniques (DLS, SEM, UV-VIS absorption and FT-IR spectroscopy) for 
the stable deposition on PEG-CH3 grafted Nylon 6 samples. The experiments confirmed the 
possibility of Cu NPs physisorption on PEG-CH3 grafted samples whereas it failed on pure 
Nylon 6 and reduced Nylon 6-NH samples. Cu NP deposited samples were found to be 
significantly efficient in both qualitative and quantitative antibacterial efficacy. Although the 
Nylon 6-N-PEG-CH3-Cu demonstrated cytotoxicity for fibroblast cells under direct contact, 
the extract of the sample was confirmed to be noncytotoxic at 5 mg/ ml concentration. The 
antibacterial efficacy can be compared and thus improved further by using other different 
sizes of Cu NPs deposited on grafted Nylon 6 surface.  
 Fourth, the synthesis of mesoporous silica materials and their application for L-DOPA 
drug delivery were achieved successfully. The SEM and BET techniques were applied to 
evaluate the morphology and particle characteristics (surface areas, pore volumes and pore 
size distributions). The L-DOPA drug loading and release were successfully evaluated by 
UV-VIS absorption spectra. A comparative study on L-DOPA drug delivery efficiency among 
all the prepared mesoporous silica samples was performed confirming SBA-15 as the most 
efficient for both L-DOPA loading and release. The behaviour of drug delivery profile 
suggested that the pore size of MSNs plays much more important role than the surface 
morphologies as all the MCM-41 (FS/ HO/ S) samples, with nearly similar pore size, 
demonstrated almost same drug delivery profiles, although their surface morphologies were 
very different.  
5.2. Future Work  
 Both bio-stable polyesters and polyamides are used in the field of biomedicine. The 
further functionalization of PET may be possible for important applications related to new 
types of antibacterial and biocompatible materials. The Nylon 6 surface modification via 
lithiation and grafting can further be explored by using different combinations of BuLi 
concentrations and PEG having various higher molecular weights (Mw > 2000) for the 
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further study aiming the improvement in antibacterial efficacy. Cu NPs with different other 
sizes can be deposited to grafted Nylon 6 samples to study the effect for bacterial resistance 
with the size of Cu NPs. Immobilization od other antibacterial NPs can also be explored for 
enhancing the efficacy of biomaterial. The mesoporous silica materials are popular in 
research areas to study the potency of different drug delivery. In our research, we have 
studied the L-DOPA drug loading on and release by some selected mesoporous silica 
materials. We have noticed that L-DOPA loading is quite fast and 2 h was reasonable time 
for complete loading. Therefore, further investigation of the loading profile between 0 – 2 h 
would be interesting. Besides, there is a scope of continuing the further comparative study 
on the same topic by functionalizing the mesoporous silica with different functional groups, 
such as terminal primary amine (-NH2), thiol (-SH) and alkyl groups (-R) etc. to increase the 
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